                         SEQUENCE LISTING

<110>  H. Lee Moffitt Cancer Center and Research Institute, Inc.
       University of South Florida
       McLaughlin, Mark
       Hazlehurst, Lori
       Jain, Priyesh
       Emmons, Michael
       Gebhard, Anthony
       Nair, Rajesh
 
<120>  Peptides for the Treatment of Cancer

<130>  MOF.144XC1PCT

<150>  61/644,938
<151>  2012-05-09

<160>  342   

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: D-Pro-L-Pro

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  1

Lys Leu Lys Leu Lys Xaa Met Val Val Ser Trp Xaa 
1               5                   10          


<210>  2
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  2

Lys Leu Lys Leu Lys Xaa Met Val Val Ser Trp Xaa 
1               5                   10          


<210>  3
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  3

Lys Leu Lys Leu Lys Xaa Met Val Val Ser Ala Xaa 
1               5                   10          


<210>  4
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  4

Lys Leu Lys Leu Lys Xaa Met Val Val Ala Trp Xaa 
1               5                   10          


<210>  5
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  5

Lys Leu Lys Leu Lys Xaa Met Val Ala Ser Trp Xaa 
1               5                   10          


<210>  6
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  6

Lys Leu Lys Leu Lys Xaa Met Ala Val Ser Trp Xaa 
1               5                   10          


<210>  7
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  7

Lys Leu Lys Leu Lys Xaa Ala Val Val Ser Trp Xaa 
1               5                   10          


<210>  8
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  8

Lys Leu Lys Leu Lys Xaa Leu Val Val Ser Trp Xaa 
1               5                   10          


<210>  9
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  9

Lys Leu Lys Leu Lys Xaa Leu Val Val Tyr Trp Xaa 
1               5                   10          


<210>  10
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  10

Lys Leu Lys Leu Lys Xaa Trp Ser Val Val Met Xaa 
1               5                   10          


<210>  11
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  11

Lys Leu Lys Leu Lys Xaa Trp Ala Val Val Leu Xaa 
1               5                   10          


<210>  12
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  12

Lys Leu Lys Leu Lys Xaa Trp Ala Val Val Ala Xaa 
1               5                   10          


<210>  13
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  13

Lys Leu Lys Leu Lys Xaa Trp Ala Val Ala Leu Xaa 
1               5                   10          


<210>  14
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  14

Lys Leu Lys Leu Lys Xaa Trp Ala Ala Val Leu Xaa 
1               5                   10          


<210>  15
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  15

Lys Leu Lys Leu Lys Xaa Ala Ala Val Val Leu Xaa 
1               5                   10          


<210>  16
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<400>  16

Lys Leu Lys Leu Lys Xaa Leu Val Val Ala Trp Xaa 
1               5                   10          


<210>  17
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<400>  17

Lys Leu Lys Gln Lys Xaa Leu Val Val Ala Trp Xaa 
1               5                   10          


<210>  18
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<400>  18

Gln Leu Lys Leu Lys Xaa Leu Val Val Ala Trp Xaa 
1               5                   10          


<210>  19
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<400>  19

Lys Leu Lys Leu Gln Xaa Leu Val Val Ala Trp Xaa 
1               5                   10          


<210>  20
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<400>  20

Lys Gln Lys Leu Lys Xaa Leu Val Val Ala Trp Xaa 
1               5                   10          


<210>  21
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<400>  21

Lys Leu Lys Gln Lys Xaa Leu Val Val Ala Trp Xaa 
1               5                   10          


<210>  22
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<400>  22

Lys Leu Lys Leu Lys Xaa Trp Ala Val Val Leu Xaa 
1               5                   10          


<210>  23
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<400>  23

Lys Xaa Lys Xaa Lys Xaa Trp Ala Val Val Leu Xaa 
1               5                   10          


<210>  24
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<400>  24

Lys Leu Lys Leu Lys Xaa Leu Val Leu Ala Trp Xaa 
1               5                   10          


<210>  25
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<400>  25

Lys Leu Lys Leu Lys Xaa Leu Val Ile Ala Trp Xaa 
1               5                   10          


<210>  26
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic III peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<400>  26

Lys Leu Lys Leu Lys Xaa Leu Val Phe Ala Trp Xaa 
1               5                   10          


<210>  27
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  HYD1 peptide sequence

<400>  27

Lys Ile Lys Met Val Ile Ser Trp Lys Gly 
1               5                   10  


<210>  28
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  putative HYD1 core region

<400>  28

Met Val Ile Ser Trp 
1               5   


<210>  29
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  core bioactive sequence of HYD1

<400>  29

Met Val Val Ser Trp 
1               5   


<210>  30
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  modified core sequence of HYD1


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Norleucine

<400>  30

Leu Val Val Ser Trp 
1               5   


<210>  31
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  modified core sequence of HYD1

<400>  31

Met Val Val Ala Trp 
1               5   


<210>  32
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  modified core sequence of HYD1


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Norleucine

<400>  32

Leu Val Val Ala Trp 
1               5   


<210>  33
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  bioactive sequence

<400>  33

Trp Ser Val Val Met 
1               5   


<210>  34
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-recognition sequence

<400>  34

Lys Leu Lys Leu Lys 
1               5   


<210>  35
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition strand of inverso cyclic III peptide analog


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Norleucine

<400>  35

Trp Ala Val Val Leu 
1               5   


<210>  36
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  RZ-3 peptide sequence

<400>  36

Lys Met Val Ile Tyr Trp Lys Ala Gly 
1               5                   


<210>  37
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition strand of cyclic III peptide analog


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Norleucine

<400>  37

Asn Val Val Tyr Trp 
1               5   


<210>  38
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-recognition sequences of cyclic peptides

<400>  38

Lys Leu Gln Leu Lys 
1               5   


<210>  39
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-recognition sequence of cyclic peptides

<400>  39

Gln Leu Lys Leu Lys 
1               5   


<210>  40
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-recognition sequence of cyclic peptides

<400>  40

Lys Gln Lys Leu Lys 
1               5   


<210>  41
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  sarcosine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  sarcosine

<400>  41

Lys Xaa Lys Xaa Lys 
1               5   


<210>  42
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-recognition sequence of cyclic peptides

<400>  42

Glu Leu Lys Leu Lys 
1               5   


<210>  43
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  43

Trp Ala Val Ala Trp 
1               5   


<210>  44
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  44

Trp Ala Val Ala Ala 
1               5   


<210>  45
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  45

Trp Ala Val Ala Met 
1               5   


<210>  46
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  46

Trp Ala Val Ala Leu 
1               5   


<210>  47
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  47

Trp Ala Val Ser Leu 
1               5   


<210>  48
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  48

Trp Ala Ala Ala Trp 
1               5   


<210>  49
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  49

Trp Ala Ala Ala Ala 
1               5   


<210>  50
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  50

Trp Ala Ala Ala Met 
1               5   


<210>  51
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  51

Trp Ala Ala Ala Leu 
1               5   


<210>  52
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  52

Trp Ala Ala Val Trp 
1               5   


<210>  53
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  53

Trp Ala Ala Val Ala 
1               5   


<210>  54
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  54

Trp Ala Ala Val Met 
1               5   


<210>  55
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  55

Trp Ala Ala Val Leu 
1               5   


<210>  56
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  56

Trp Ala Ala Ser Leu 
1               5   


<210>  57
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  57

Trp Val Val Ala Trp 
1               5   


<210>  58
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  58

Trp Val Val Ala Ala 
1               5   


<210>  59
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  59

Trp Val Val Ala Met 
1               5   


<210>  60
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  60

Trp Val Val Ala Leu 
1               5   


<210>  61
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  61

Trp Val Val Val Trp 
1               5   


<210>  62
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  62

Trp Val Val Val Ala 
1               5   


<210>  63
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  63

Trp Val Val Val Met 
1               5   


<210>  64
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  64

Trp Val Val Val Leu 
1               5   


<210>  65
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  65

Trp Val Val Ser Leu 
1               5   


<210>  66
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  66

Trp Val Ala Ala Leu 
1               5   


<210>  67
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  67

Trp Val Ala Val Trp 
1               5   


<210>  68
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  68

Trp Val Ala Val Ala 
1               5   


<210>  69
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  69

Trp Val Ala Val Met 
1               5   


<210>  70
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  70

Trp Val Ala Val Leu 
1               5   


<210>  71
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  71

Trp Val Ala Ser Leu 
1               5   


<210>  72
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  72

Trp Ser Val Ala Trp 
1               5   


<210>  73
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  73

Trp Ser Val Ala Ala 
1               5   


<210>  74
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  74

Trp Ser Val Ala Met 
1               5   


<210>  75
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  75

Trp Ser Val Ala Leu 
1               5   


<210>  76
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  76

Trp Ser Val Val Trp 
1               5   


<210>  77
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  77

Trp Ser Val Val Ala 
1               5   


<210>  78
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  78

Trp Ser Val Val Leu 
1               5   


<210>  79
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  79

Trp Ser Val Ser Trp 
1               5   


<210>  80
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  80

Trp Ser Val Ser Ala 
1               5   


<210>  81
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  81

Trp Ser Val Ser Met 
1               5   


<210>  82
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  82

Trp Ser Val Ser Leu 
1               5   


<210>  83
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  83

Trp Ser Ala Ala Trp 
1               5   


<210>  84
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  84

Trp Ser Ala Ala Ala 
1               5   


<210>  85
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  85

Trp Ser Ala Ala Met 
1               5   


<210>  86
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  86

Trp Ser Ala Ala Leu 
1               5   


<210>  87
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  87

Trp Ser Ala Val Trp 
1               5   


<210>  88
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  88

Trp Ser Ala Val Ala 
1               5   


<210>  89
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  89

Trp Ser Ala Val Met 
1               5   


<210>  90
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  90

Trp Ser Ala Val Leu 
1               5   


<210>  91
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  91

Trp Ser Ala Ser Trp 
1               5   


<210>  92
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  92

Trp Ser Ala Ser Ala 
1               5   


<210>  93
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  93

Trp Ser Ala Ser Met 
1               5   


<210>  94
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  94

Trp Ser Ala Ser Leu 
1               5   


<210>  95
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  95

Trp Tyr Val Ala Trp 
1               5   


<210>  96
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  96

Trp Tyr Val Ala Ala 
1               5   


<210>  97
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  97

Trp Tyr Val Ala Met 
1               5   


<210>  98
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  98

Trp Tyr Val Ala Leu 
1               5   


<210>  99
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  99

Trp Tyr Val Val Trp 
1               5   


<210>  100
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  100

Trp Tyr Val Val Ala 
1               5   


<210>  101
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  101

Trp Tyr Val Val Met 
1               5   


<210>  102
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  102

Trp Tyr Val Val Leu 
1               5   


<210>  103
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  103

Trp Tyr Val Ser Trp 
1               5   


<210>  104
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  104

Trp Tyr Val Ser Ala 
1               5   


<210>  105
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  105

Trp Tyr Val Ser Met 
1               5   


<210>  106
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  106

Trp Tyr Val Ser Leu 
1               5   


<210>  107
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  107

Trp Tyr Ala Ala Trp 
1               5   


<210>  108
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  108

Trp Tyr Ala Ala Ala 
1               5   


<210>  109
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  109

Trp Tyr Ala Ala Met 
1               5   


<210>  110
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  110

Trp Tyr Ala Ala Leu 
1               5   


<210>  111
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  111

Trp Tyr Ala Val Trp 
1               5   


<210>  112
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  112

Trp Tyr Ala Val Ala 
1               5   


<210>  113
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  113

Trp Tyr Ala Val Met 
1               5   


<210>  114
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  114

Trp Tyr Ala Val Leu 
1               5   


<210>  115
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  115

Trp Tyr Ala Ser Trp 
1               5   


<210>  116
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  116

Trp Tyr Ala Ser Ala 
1               5   


<210>  117
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  117

Trp Tyr Ala Ser Met 
1               5   


<210>  118
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  118

Trp Tyr Ala Ser Leu 
1               5   


<210>  119
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  119

Ala Ala Val Ala Ala 
1               5   


<210>  120
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  120

Ala Ala Val Ala Met 
1               5   


<210>  121
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  121

Ala Ala Val Ala Leu 
1               5   


<210>  122
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  122

Ala Ala Val Val Leu 
1               5   


<210>  123
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  123

Ala Ala Val Ser Leu 
1               5   


<210>  124
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  124

Ala Ala Ala Ala Ala 
1               5   


<210>  125
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  125

Ala Ala Ala Ala Met 
1               5   


<210>  126
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  126

Ala Ala Ala Ala Leu 
1               5   


<210>  127
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  127

Ala Ala Ala Val Trp 
1               5   


<210>  128
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  128

Ala Ala Ala Val Ala 
1               5   


<210>  129
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  129

Ala Ala Ala Val Met 
1               5   


<210>  130
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  130

Ala Ala Ala Val Leu 
1               5   


<210>  131
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  131

Ala Ala Ala Ser Met 
1               5   


<210>  132
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  132

Ala Ala Ala Ser Leu 
1               5   


<210>  133
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  133

Ala Val Val Ala Trp 
1               5   


<210>  134
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  134

Ala Val Val Ala Ala 
1               5   


<210>  135
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  135

Ala Val Val Ala Met 
1               5   


<210>  136
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  136

Ala Val Val Ala Leu 
1               5   


<210>  137
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  137

Ala Val Val Val Ala 
1               5   


<210>  138
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  138

Ala Val Val Val Met 
1               5   


<210>  139
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  139

Ala Val Val Val Leu 
1               5   


<210>  140
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  140

Ala Val Val Ser Leu 
1               5   


<210>  141
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  141

Ala Val Ala Ala Trp 
1               5   


<210>  142
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  142

Ala Val Ala Ala Met 
1               5   


<210>  143
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  143

Ala Val Ala Ala Leu 
1               5   


<210>  144
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  144

Ala Val Ala Val Ala 
1               5   


<210>  145
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  145

Ala Val Ala Val Met 
1               5   


<210>  146
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  146

Ala Val Ala Val Leu 
1               5   


<210>  147
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  147

Ala Val Ala Ser Leu 
1               5   


<210>  148
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  148

Ala Ser Val Ala Trp 
1               5   


<210>  149
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  149

Ala Ser Val Ala Ala 
1               5   


<210>  150
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  150

Ala Ser Val Ala Met 
1               5   


<210>  151
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  151

Ala Ser Val Ala Leu 
1               5   


<210>  152
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  152

Ala Ser Val Val Trp 
1               5   


<210>  153
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  153

Ala Ser Val Val Ala 
1               5   


<210>  154
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  154

Ala Ser Val Val Met 
1               5   


<210>  155
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  155

Ala Ser Val Val Leu 
1               5   


<210>  156
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  156

Ala Ser Val Ser Ala 
1               5   


<210>  157
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  157

Ala Ser Val Ser Met 
1               5   


<210>  158
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  158

Ala Ser Val Ser Leu 
1               5   


<210>  159
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  159

Ala Ser Ala Ala Trp 
1               5   


<210>  160
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  160

Ala Ser Ala Ala Ala 
1               5   


<210>  161
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  161

Ala Ser Ala Ala Met 
1               5   


<210>  162
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  162

Ala Ser Ala Ala Leu 
1               5   


<210>  163
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  163

Ala Ser Ala Val Trp 
1               5   


<210>  164
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  164

Ala Ser Ala Val Ala 
1               5   


<210>  165
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  165

Ala Ser Ala Val Met 
1               5   


<210>  166
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  166

Ala Ser Ala Val Leu 
1               5   


<210>  167
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  167

Ala Ser Ala Ser Ala 
1               5   


<210>  168
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  168

Ala Ser Ala Ser Met 
1               5   


<210>  169
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  169

Ala Ser Ala Ser Leu 
1               5   


<210>  170
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  170

Ala Tyr Val Ala Trp 
1               5   


<210>  171
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  171

Ala Tyr Val Ala Ala 
1               5   


<210>  172
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  172

Ala Tyr Val Ala Met 
1               5   


<210>  173
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  173

Ala Tyr Val Ala Leu 
1               5   


<210>  174
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  174

Ala Tyr Val Val Trp 
1               5   


<210>  175
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  175

Ala Tyr Val Val Ala 
1               5   


<210>  176
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  176

Ala Tyr Val Val Met 
1               5   


<210>  177
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  177

Ala Tyr Val Val Leu 
1               5   


<210>  178
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  178

Ala Tyr Val Ser Trp 
1               5   


<210>  179
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  179

Ala Tyr Val Ser Ala 
1               5   


<210>  180
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  180

Ala Tyr Val Ser Met 
1               5   


<210>  181
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  181

Ala Tyr Val Ser Leu 
1               5   


<210>  182
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  182

Ala Tyr Ala Ala Trp 
1               5   


<210>  183
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  183

Ala Tyr Ala Ala Ala 
1               5   


<210>  184
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  184

Ala Tyr Ala Ala Met 
1               5   


<210>  185
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  185

Ala Tyr Ala Ala Leu 
1               5   


<210>  186
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  186

Ala Tyr Ala Val Trp 
1               5   


<210>  187
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  187

Ala Tyr Ala Val Ala 
1               5   


<210>  188
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  188

Ala Tyr Ala Val Met 
1               5   


<210>  189
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  189

Ala Tyr Ala Val Leu 
1               5   


<210>  190
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  190

Ala Tyr Ala Ser Trp 
1               5   


<210>  191
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  191

Ala Tyr Ala Ser Ala 
1               5   


<210>  192
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  192

Ala Tyr Ala Ser Met 
1               5   


<210>  193
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  193

Ala Tyr Ala Ser Leu 
1               5   


<210>  194
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  194

Met Ala Val Ala Ala 
1               5   


<210>  195
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  195

Met Ala Val Ala Met 
1               5   


<210>  196
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  196

Met Ala Val Ala Leu 
1               5   


<210>  197
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  197

Met Ala Val Val Leu 
1               5   


<210>  198
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  198

Met Ala Val Ser Leu 
1               5   


<210>  199
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  199

Met Ala Ala Ala Ala 
1               5   


<210>  200
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  200

Met Ala Ala Ala Met 
1               5   


<210>  201
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  201

Met Ala Ala Ala Leu 
1               5   


<210>  202
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  202

Met Ala Ala Val Trp 
1               5   


<210>  203
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  203

Met Ala Ala Val Ala 
1               5   


<210>  204
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  204

Met Ala Ala Val Met 
1               5   


<210>  205
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  205

Met Ala Ala Val Leu 
1               5   


<210>  206
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  206

Met Ala Ala Ser Leu 
1               5   


<210>  207
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  207

Met Val Val Ala Ala 
1               5   


<210>  208
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  208

Met Val Val Ala Met 
1               5   


<210>  209
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  209

Met Val Val Ala Leu 
1               5   


<210>  210
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  210

Met Val Val Val Met 
1               5   


<210>  211
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  211

Met Val Val Val Leu 
1               5   


<210>  212
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  212

Met Val Val Ser Leu 
1               5   


<210>  213
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  213

Met Val Ala Ala Met 
1               5   


<210>  214
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  214

Met Val Ala Ala Leu 
1               5   


<210>  215
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  215

Met Val Ala Val Met 
1               5   


<210>  216
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  216

Met Val Ala Val Leu 
1               5   


<210>  217
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  217

Met Val Ala Ser Leu 
1               5   


<210>  218
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  218

Met Ser Val Ala Trp 
1               5   


<210>  219
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  219

Met Ser Val Ala Ala 
1               5   


<210>  220
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  220

Met Ser Val Ala Met 
1               5   


<210>  221
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  221

Met Ser Val Ala Leu 
1               5   


<210>  222
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  222

Met Ser Val Val Trp 
1               5   


<210>  223
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  223

Met Ser Val Val Ala 
1               5   


<210>  224
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  224

Met Ser Val Val Met 
1               5   


<210>  225
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  225

Met Ser Val Val Leu 
1               5   


<210>  226
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  226

Met Ser Val Ser Met 
1               5   


<210>  227
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  227

Met Ser Val Ser Leu 
1               5   


<210>  228
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  228

Met Ser Ala Ala Trp 
1               5   


<210>  229
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  229

Met Ser Ala Ala Ala 
1               5   


<210>  230
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  230

Met Ser Ala Ala Met 
1               5   


<210>  231
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  231

Met Ser Ala Ala Leu 
1               5   


<210>  232
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  232

Met Ser Ala Val Trp 
1               5   


<210>  233
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  233

Met Ser Ala Val Ala 
1               5   


<210>  234
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  234

Met Ser Ala Val Met 
1               5   


<210>  235
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  235

Met Ser Ala Val Leu 
1               5   


<210>  236
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  236

Met Ser Ala Ser Met 
1               5   


<210>  237
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  237

Met Ser Ala Ser Leu 
1               5   


<210>  238
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  238

Met Tyr Val Ala Trp 
1               5   


<210>  239
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  239

Met Tyr Val Ala Ala 
1               5   


<210>  240
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  240

Met Tyr Val Ala Met 
1               5   


<210>  241
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  241

Met Tyr Val Ala Leu 
1               5   


<210>  242
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  242

Met Tyr Val Val Trp 
1               5   


<210>  243
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  243

Met Tyr Val Val Ala 
1               5   


<210>  244
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  244

Met Tyr Val Val Met 
1               5   


<210>  245
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  245

Met Tyr Val Val Leu 
1               5   


<210>  246
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  246

Met Tyr Val Ser Trp 
1               5   


<210>  247
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  247

Met Tyr Val Ser Ala 
1               5   


<210>  248
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  248

Met Tyr Val Ser Met 
1               5   


<210>  249
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  249

Met Tyr Val Ser Leu 
1               5   


<210>  250
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  250

Met Tyr Ala Ala Trp 
1               5   


<210>  251
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  251

Met Tyr Ala Ala Ala 
1               5   


<210>  252
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  252

Met Tyr Ala Ala Met 
1               5   


<210>  253
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  253

Met Tyr Ala Ala Leu 
1               5   


<210>  254
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  254

Met Tyr Ala Val Trp 
1               5   


<210>  255
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  255

Met Tyr Ala Val Ala 
1               5   


<210>  256
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  256

Met Tyr Ala Val Met 
1               5   


<210>  257
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  257

Met Tyr Ala Val Leu 
1               5   


<210>  258
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  258

Met Tyr Ala Ser Trp 
1               5   


<210>  259
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  259

Met Tyr Ala Ser Ala 
1               5   


<210>  260
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  260

Met Tyr Ala Ser Met 
1               5   


<210>  261
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<400>  261

Met Tyr Ala Ser Leu 
1               5   


<210>  262
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  262

Met Val Val Ser Ala 
1               5   


<210>  263
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  263

Met Val Ala Ser Trp 
1               5   


<210>  264
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  264

Met Ala Val Ser Trp 
1               5   


<210>  265
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides

<400>  265

Ala Val Val Ser Trp 
1               5   


<210>  266
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  norleucine

<400>  266

Leu Ala Val Ala Trp 
1               5   


<210>  267
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  norleucine

<400>  267

Leu Val Ala Ala Trp 
1               5   


<210>  268
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  norleucine

<400>  268

Leu Val Leu Ala Trp 
1               5   


<210>  269
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  norleucine

<400>  269

Leu Val Ile Ala Trp 
1               5   


<210>  270
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  recognition sequence of cyclic peptides


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  norleucine

<400>  270

Leu Val Phe Ala Trp 
1               5   


<210>  271
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  271

Ala Ile Ala Met Val Ile Ser Trp Ala Gly 
1               5                   10  


<210>  272
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  272

Ala Ile Lys Met Val Ile Ser Trp Ala Gly 
1               5                   10  


<210>  273
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  273

Ala Ile Lys Met Val Ile Ser Trp Lys Gly 
1               5                   10  


<210>  274
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  274

Ala Lys Met Val Ile Ser Trp 
1               5           


<210>  275
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  275

Ala Lys Met Val Ile Ser Trp Lys Gly 
1               5                   


<210>  276
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  276

Ile Ala Met Val Ile Ser Trp 
1               5           


<210>  277
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  277

Ile Ala Met Val Ile Ser Trp Lys Gly 
1               5                   


<210>  278
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  278

Ile Lys Ala Val Ile Ser Trp 
1               5           


<210>  279
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  279

Ile Lys Ala Val Ile Ser Trp Lys Gly 
1               5                   


<210>  280
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  280

Ile Lys Met Ala Ile Ser Trp 
1               5           


<210>  281
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  281

Ile Lys Met Ala Ile Ser Trp Lys Gly 
1               5                   


<210>  282
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  282

Ile Lys Met Val Ala Ser Trp 
1               5           


<210>  283
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  283

Ile Lys Met Val Ala Ser Trp Lys Gly 
1               5                   


<210>  284
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  284

Ile Lys Met Val Ile Ala Trp 
1               5           


<210>  285
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  285

Ile Lys Met Val Ile Ala Trp Lys Gly 
1               5                   


<210>  286
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  286

Ile Lys Met Val Ile Ser Ala 
1               5           


<210>  287
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  287

Ile Lys Met Val Ile Ser Ala Lys Gly 
1               5                   


<210>  288
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  288

Ile Lys Met Val Ile Ser Trp 
1               5           


<210>  289
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  289

Ile Lys Met Val Ile Ser Trp Ala Gly 
1               5                   


<210>  290
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  290

Lys Met Val Ile Ser Trp Lys Ala 
1               5               


<210>  291
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  291

Ile Lys Met Val Ile Ser Trp Lys Gly 
1               5                   


<210>  292
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  292

Ile Ser Trp Lys Gly 
1               5   


<210>  293
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  293

Lys Ala Lys Met Val Ile Ser Trp Lys Gly 
1               5                   10  


<210>  294
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  294

Lys Ile Ala Met Val Ile Ser Trp Ala Gly 
1               5                   10  


<210>  295
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  295

Lys Ile Ala Met Val Ile Ser Trp Lys Gly 
1               5                   10  


<210>  296
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  296

Lys Ile Lys Ala Val Ile Ser Trp Lys Gly 
1               5                   10  


<210>  297
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  297

Lys Ile Lys Met Ala Ile Ser Trp Lys Gly 
1               5                   10  


<210>  298
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  298

Lys Ile Lys Met Val 
1               5   


<210>  299
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  299

Lys Ile Lys Met Val Ala Ser Trp Lys Gly 
1               5                   10  


<210>  300
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  300

Lys Ile Lys Met Val Ile 
1               5       


<210>  301
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  301

Lys Ile Lys Met Val Ile Ala Trp Lys Gly 
1               5                   10  


<210>  302
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  302

Lys Ile Lys Met Val Ile Ser 
1               5           


<210>  303
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  303

Lys Ile Lys Met Val Ile Ser Ala Lys Gly 
1               5                   10  


<210>  304
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  304

Lys Ile Lys Met Val Ile Ser Trp 
1               5               


<210>  305
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  305

Lys Ile Lys Met Val Ile Ser Trp Ala Gly 
1               5                   10  


<210>  306
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  306

Lys Ile Lys Met Val Ile Ser Trp Lys 
1               5                   


<210>  307
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  307

Lys Ile Lys Met Val Ile Ser Trp Lys Ala 
1               5                   10  


<210>  308
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  308

Lys Met Val Ile Ser Trp Lys Gly 
1               5               


<210>  309
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  309

Leu Ser Trp Lys Gly 
1               5   


<210>  310
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  310

Met Val Ile Ser Trp Lys Gly 
1               5           


<210>  311
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  311

Ser Trp Lys Gly 
1               


<210>  312
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  312

Val Ile Ser Trp Lys Gly 
1               5       


<210>  313
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide

<400>  313

Trp Ile Lys Ser Met Lys Ile Val Lys Gly 
1               5                   10  


<210>  314
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide


<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa can be any naturally occurring amino acid

<400>  314

Lys Met Val Ile Xaa Trp 
1               5       


<210>  315
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide


<220>
<221>  misc_feature
<222>  (8)..(9)
<223>  Xaa can be any naturally occurring amino acid

<400>  315

Ile Lys Met Val Ile Ser Trp Xaa Xaa 
1               5                   


<210>  316
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  non-cyclic HYD1 peptide


<220>
<221>  misc_feature
<222>  (7)..(8)
<223>  Xaa can be any naturally occurring amino acid

<400>  316

Lys Met Val Ile Ser Trp Xaa Xaa 
1               5               


<210>  317
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: D-Pro-L-Pro

<400>  317

Lys Leu Lys Leu Lys Xaa Met Val Val Ser Trp Xaa 
1               5                   10          


<210>  318
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  318

Lys Leu Lys Leu Lys Xaa Leu Val Val Ala Trp Xaa 
1               5                   10          


<210>  319
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  319

Lys Leu Gln Leu Lys Xaa Leu Val Val Ala Trp Xaa 
1               5                   10          


<210>  320
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  320

Gln Leu Lys Leu Lys Xaa Leu Val Val Ala Trp Xaa 
1               5                   10          


<210>  321
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  321

Lys Leu Lys Leu Gln Xaa Leu Val Val Ala Trp Xaa 
1               5                   10          


<210>  322
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  322

Lys Gln Lys Leu Lys Xaa Leu Val Val Ala Trp Xaa 
1               5                   10          


<210>  323
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  323

Lys Leu Lys Gln Lys Xaa Leu Val Val Ala Trp Xaa 
1               5                   10          


<210>  324
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  324

Lys Leu Lys Leu Lys Xaa Leu Val Leu Ala Trp Xaa 
1               5                   10          


<210>  325
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  325

Lys Leu Lys Leu Lys Xaa Leu Val Ile Ala Trp Xaa 
1               5                   10          


<210>  326
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Beta-turn promoter: (pyrrolidin-2-ylmethoxy)acetate

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Beta-turn promoter: methylsulfonamido aminoethylglycine

<400>  326

Lys Leu Lys Leu Lys Xaa Leu Val Phe Ala Trp Xaa 
1               5                   10          


<210>  327
<211>  5748
<212>  DNA
<213>  Homo sapiens

<400>  327
gagaagaaag ccagtgcgtc tctgggcgca ggggccagtg gggctcggag gcacaggcac       60

cccgcgacac tccaggttcc ccgacccacg tccctggcag ccccgattat ttacagcctc      120

agcagagcac ggggcggggg cagaggggcc cgcccgggag ggctgctact tcttaaaacc      180

tctgcgggct gcttagtcac agcccccctt gcttgggtgt gtccttcgct cgctccctcc      240

ctccgtctta ggtcactgtt ttcaacctcg aataaaaact gcagccaact tccgaggcag      300

cctcattgcc cagcggaccc cagcctctgc caggttcggt ccgccatcct cgtcccgtcc      360

tccgccggcc cctgccccgc gcccagggat cctccagctc ctttcgcccg cgccctccgt      420

tcgctccgga caccatggac aagttttggt ggcacgcagc ctggggactc tgcctcgtgc      480

cgctgagcct ggcgcagatc gatttgaata taacctgccg ctttgcaggt gtattccacg      540

tggagaaaaa tggtcgctac agcatctctc ggacggaggc cgctgacctc tgcaaggctt      600

tcaatagcac cttgcccaca atggcccaga tggagaaagc tctgagcatc ggatttgaga      660

cctgcaggta tgggttcata gaagggcacg tggtgattcc ccggatccac cccaactcca      720

tctgtgcagc aaacaacaca ggggtgtaca tcctcacatc caacacctcc cagtatgaca      780

catattgctt caatgcttca gctccacctg aagaagattg tacatcagtc acagacctgc      840

ccaatgcctt tgatggacca attaccataa ctattgttaa ccgtgatggc acccgctatg      900

tccagaaagg agaatacaga acgaatcctg aagacatcta ccccagcaac cctactgatg      960

atgacgtgag cagcggctcc tccagtgaaa ggagcagcac ttcaggaggt tacatctttt     1020

acaccttttc tactgtacac cccatcccag acgaagacag tccctggatc accgacagca     1080

cagacagaat ccctgctacc actttgatga gcactagtgc tacagcaact gagacagcaa     1140

ccaagaggca agaaacctgg gattggtttt catggttgtt tctaccatca gagtcaaaga     1200

atcatcttca cacaacaaca caaatggctg gtacgtcttc aaataccatc tcagcaggct     1260

gggagccaaa tgaagaaaat gaagatgaaa gagacagaca cctcagtttt tctggatcag     1320

gcattgatga tgatgaagat tttatctcca gcaccatttc aaccacacca cgggcttttg     1380

accacacaaa acagaaccag gactggaccc agtggaaccc aagccattca aatccggaag     1440

tgctacttca gacaaccaca aggatgactg atgtagacag aaatggcacc actgcttatg     1500

aaggaaactg gaacccagaa gcacaccctc ccctcattca ccatgagcat catgaggaag     1560

aagagacccc acattctaca agcacaatcc aggcaactcc tagtagtaca acggaagaaa     1620

cagctaccca gaaggaacag tggtttggca acagatggca tgagggatat cgccaaacac     1680

ccaaagaaga ctcccattcg acaacaggga cagctgcagc ctcagctcat accagccatc     1740

caatgcaagg aaggacaaca ccaagcccag aggacagttc ctggactgat ttcttcaacc     1800

caatctcaca ccccatggga cgaggtcatc aagcaggaag aaggatggat atggactcca     1860

gtcatagtat aacgcttcag cctactgcaa atccaaacac aggtttggtg gaagatttgg     1920

acaggacagg acctctttca atgacaacgc agcagagtaa ttctcagagc ttctctacat     1980

cacatgaagg cttggaagaa gataaagacc atccaacaac ttctactctg acatcaagca     2040

ataggaatga tgtcacaggt ggaagaagag acccaaatca ttctgaaggc tcaactactt     2100

tactggaagg ttatacctct cattacccac acacgaagga aagcaggacc ttcatcccag     2160

tgacctcagc taagactggg tcctttggag ttactgcagt tactgttgga gattccaact     2220

ctaatgtcaa tcgttcctta tcaggagacc aagacacatt ccaccccagt ggggggtccc     2280

ataccactca tggatctgaa tcagatggac actcacatgg gagtcaagaa ggtggagcaa     2340

acacaacctc tggtcctata aggacacccc aaattccaga atggctgatc atcttggcat     2400

ccctcttggc cttggctttg attcttgcag tttgcattgc agtcaacagt cgaagaaggt     2460

gtgggcagaa gaaaaagcta gtgatcaaca gtggcaatgg agctgtggag gacagaaagc     2520

caagtggact caacggagag gccagcaagt ctcaggaaat ggtgcatttg gtgaacaagg     2580

agtcgtcaga aactccagac cagtttatga cagctgatga gacaaggaac ctgcagaatg     2640

tggacatgaa gattggggtg taacacctac accattatct tggaaagaaa caaccgttgg     2700

aaacataacc attacaggga gctgggacac ttaacagatg caatgtgcta ctgattgttt     2760

cattgcgaat cttttttagc ataaaatttt ctactctttt tgttttttgt gttttgttct     2820

ttaaagtcag gtccaatttg taaaaacagc attgctttct gaaattaggg cccaattaat     2880

aatcagcaag aatttgatcg ttccagttcc cacttggagg cctttcatcc ctcgggtgtg     2940

ctatggatgg cttctaacaa aaactacaca tatgtattcc tgatcgccaa cctttccccc     3000

accagctaag gacatttccc agggttaata gggcctggtc cctgggagga aatttgaatg     3060

ggtccatttt gcccttccat agcctaatcc ctgggcattg ctttccactg aggttggggg     3120

ttggggtgta ctagttacac atcttcaaca gaccccctct agaaattttt cagatgcttc     3180

tgggagacac ccaaagggtg aagctattta tctgtagtaa actatttatc tgtgtttttg     3240

aaatattaaa ccctggatca gtcctttgat cagtataatt ttttaaagtt actttgtcag     3300

aggcacaaaa gggtttaaac tgattcataa taaatatctg tacttcttcg atcttcacct     3360

tttgtgctgt gattcttcag tttctaaacc agcactgtct gggtccctac aatgtatcag     3420

gaagagctga gaatggtaag gagactcttc taagtcttca tctcagagac cctgagttcc     3480

cactcagacc cactcagcca aatctcatgg aagaccaagg agggcagcac tgtttttgtt     3540

ttttgttttt tgtttttttt ttttgacact gtccaaaggt tttccatcct gtcctggaat     3600

cagagttgga agctgaggag cttcagcctc ttttatggtt taatggccac ctgttctctc     3660

ctgtgaaagg ctttgcaaag tcacattaag tttgcatgac ctgttatccc tggggcccta     3720

tttcatagag gctggcccta ttagtgattt ccaaaaacaa tatggaagtg ccttttgatg     3780

tcttacaata agagaagaag ccaatggaaa tgaaagagat tggcaaaggg gaaggatgat     3840

gccatgtaga tcctgtttga catttttatg gctgtatttg taaacttaaa cacaccagtg     3900

tctgttcttg atgcagttgc tatttaggat gagttaagtg cctggggagt ccctcaaaag     3960

gttaaaggga ttcccatcat tggaatctta tcaccagata ggcaagttta tgaccaaaca     4020

agagagtact ggctttatcc tctaacctca tattttctcc cacttggcaa gtcctttgtg     4080

gcatttattc atcagtcagg gtgtccgatt ggtcctagaa cttccaaagg ctgcttgtca     4140

tagaagccat tgcatctata aagcaacggc tcctgttaaa tggtatctcc tttctgaggc     4200

tcctactaaa agtcatttgt tacctaaact tatgtgctta acaggcaatg cttctcagac     4260

cacaaagcag aaagaagaag aaaagctcct gactaaatca gggctgggct tagacagagt     4320

tgatctgtag aatatcttta aaggagagat gtcaactttc tgcactattc ccagcctctg     4380

ctcctccctg tctaccctct cccctccctc tctccctcca cttcacccca caatcttgaa     4440

aaacttcctt tctcttctgt gaacatcatt ggccagatcc attttcagtg gtctggattt     4500

ctttttattt tcttttcaac ttgaaagaaa ctggacatta ggccactatg tgttgttact     4560

gccactagtg ttcaagtgcc tcttgttttc ccagagattt cctgggtctg ccagaggccc     4620

agacaggctc actcaagctc tttaactgaa aagcaacaag ccactccagg acaaggttca     4680

aaatggttac aacagcctct acctgtcgcc ccagggagaa aggggtagtg atacaagtct     4740

catagccaga gatggttttc cactccttct agatattccc aaaaagaggc tgagacagga     4800

ggttattttc aattttattt tggaattaaa tacttttttc cctttattac tgttgtagtc     4860

cctcacttgg atatacctct gttttcacga tagaaataag ggaggtctag agcttctatt     4920

ccttggccat tgtcaacgga gagctggcca agtcttcaca aacccttgca acattgcctg     4980

aagtttatgg aataagatgt attctcactc ccttgatctc aagggcgtaa ctctggaagc     5040

acagcttgac tacacgtcat ttttaccaat gattttcagg tgacctgggc taagtcattt     5100

aaactgggtc tttataaaag taaaaggcca acatttaatt attttgcaaa gcaacctaag     5160

agctaaagat gtaatttttc ttgcaattgt aaatcttttg tgtctcctga agacttccct     5220

taaaattagc tctgagtgaa aaatcaaaag agacaaaaga catcttcgaa tccatatttc     5280

aagcctggta gaattggctt ttctagcaga acctttccaa aagttttata ttgagattca     5340

taacaacacc aagaattgat tttgtagcca acattcattc aatactgtta tatcagagga     5400

gtaggagaga ggaaacattt gacttatctg gaaaagcaaa atgtacttaa gaataagaat     5460

aacatggtcc attcaccttt atgttataga tatgtctttg tgtaaatcat ttgttttgag     5520

ttttcaaaga atagcccatt gttcattctt gtgctgtaca atgaccactg ttattgttac     5580

tttgactttt cagagcacac ccttcctctg gtttttgtat atttattgat ggatcaataa     5640

taatgaggaa agcatgatat gtatattgct gagttgaaag cacttattgg aaaatattaa     5700

aaggctaaca ttaaaagact aaaggaaaca gaaaaaaaaa aaaaaaaa                  5748


<210>  328
<211>  742
<212>  PRT
<213>  Homo sapiens

<400>  328

Met Asp Lys Phe Trp Trp His Ala Ala Trp Gly Leu Cys Leu Val Pro 
1               5                   10                  15      


Leu Ser Leu Ala Gln Ile Asp Leu Asn Ile Thr Cys Arg Phe Ala Gly 
            20                  25                  30          


Val Phe His Val Glu Lys Asn Gly Arg Tyr Ser Ile Ser Arg Thr Glu 
        35                  40                  45              


Ala Ala Asp Leu Cys Lys Ala Phe Asn Ser Thr Leu Pro Thr Met Ala 
    50                  55                  60                  


Gln Met Glu Lys Ala Leu Ser Ile Gly Phe Glu Thr Cys Arg Tyr Gly 
65                  70                  75                  80  


Phe Ile Glu Gly His Val Val Ile Pro Arg Ile His Pro Asn Ser Ile 
                85                  90                  95      


Cys Ala Ala Asn Asn Thr Gly Val Tyr Ile Leu Thr Ser Asn Thr Ser 
            100                 105                 110         


Gln Tyr Asp Thr Tyr Cys Phe Asn Ala Ser Ala Pro Pro Glu Glu Asp 
        115                 120                 125             


Cys Thr Ser Val Thr Asp Leu Pro Asn Ala Phe Asp Gly Pro Ile Thr 
    130                 135                 140                 


Ile Thr Ile Val Asn Arg Asp Gly Thr Arg Tyr Val Gln Lys Gly Glu 
145                 150                 155                 160 


Tyr Arg Thr Asn Pro Glu Asp Ile Tyr Pro Ser Asn Pro Thr Asp Asp 
                165                 170                 175     


Asp Val Ser Ser Gly Ser Ser Ser Glu Arg Ser Ser Thr Ser Gly Gly 
            180                 185                 190         


Tyr Ile Phe Tyr Thr Phe Ser Thr Val His Pro Ile Pro Asp Glu Asp 
        195                 200                 205             


Ser Pro Trp Ile Thr Asp Ser Thr Asp Arg Ile Pro Ala Thr Thr Leu 
    210                 215                 220                 


Met Ser Thr Ser Ala Thr Ala Thr Glu Thr Ala Thr Lys Arg Gln Glu 
225                 230                 235                 240 


Thr Trp Asp Trp Phe Ser Trp Leu Phe Leu Pro Ser Glu Ser Lys Asn 
                245                 250                 255     


His Leu His Thr Thr Thr Gln Met Ala Gly Thr Ser Ser Asn Thr Ile 
            260                 265                 270         


Ser Ala Gly Trp Glu Pro Asn Glu Glu Asn Glu Asp Glu Arg Asp Arg 
        275                 280                 285             


His Leu Ser Phe Ser Gly Ser Gly Ile Asp Asp Asp Glu Asp Phe Ile 
    290                 295                 300                 


Ser Ser Thr Ile Ser Thr Thr Pro Arg Ala Phe Asp His Thr Lys Gln 
305                 310                 315                 320 


Asn Gln Asp Trp Thr Gln Trp Asn Pro Ser His Ser Asn Pro Glu Val 
                325                 330                 335     


Leu Leu Gln Thr Thr Thr Arg Met Thr Asp Val Asp Arg Asn Gly Thr 
            340                 345                 350         


Thr Ala Tyr Glu Gly Asn Trp Asn Pro Glu Ala His Pro Pro Leu Ile 
        355                 360                 365             


His His Glu His His Glu Glu Glu Glu Thr Pro His Ser Thr Ser Thr 
    370                 375                 380                 


Ile Gln Ala Thr Pro Ser Ser Thr Thr Glu Glu Thr Ala Thr Gln Lys 
385                 390                 395                 400 


Glu Gln Trp Phe Gly Asn Arg Trp His Glu Gly Tyr Arg Gln Thr Pro 
                405                 410                 415     


Lys Glu Asp Ser His Ser Thr Thr Gly Thr Ala Ala Ala Ser Ala His 
            420                 425                 430         


Thr Ser His Pro Met Gln Gly Arg Thr Thr Pro Ser Pro Glu Asp Ser 
        435                 440                 445             


Ser Trp Thr Asp Phe Phe Asn Pro Ile Ser His Pro Met Gly Arg Gly 
    450                 455                 460                 


His Gln Ala Gly Arg Arg Met Asp Met Asp Ser Ser His Ser Ile Thr 
465                 470                 475                 480 


Leu Gln Pro Thr Ala Asn Pro Asn Thr Gly Leu Val Glu Asp Leu Asp 
                485                 490                 495     


Arg Thr Gly Pro Leu Ser Met Thr Thr Gln Gln Ser Asn Ser Gln Ser 
            500                 505                 510         


Phe Ser Thr Ser His Glu Gly Leu Glu Glu Asp Lys Asp His Pro Thr 
        515                 520                 525             


Thr Ser Thr Leu Thr Ser Ser Asn Arg Asn Asp Val Thr Gly Gly Arg 
    530                 535                 540                 


Arg Asp Pro Asn His Ser Glu Gly Ser Thr Thr Leu Leu Glu Gly Tyr 
545                 550                 555                 560 


Thr Ser His Tyr Pro His Thr Lys Glu Ser Arg Thr Phe Ile Pro Val 
                565                 570                 575     


Thr Ser Ala Lys Thr Gly Ser Phe Gly Val Thr Ala Val Thr Val Gly 
            580                 585                 590         


Asp Ser Asn Ser Asn Val Asn Arg Ser Leu Ser Gly Asp Gln Asp Thr 
        595                 600                 605             


Phe His Pro Ser Gly Gly Ser His Thr Thr His Gly Ser Glu Ser Asp 
    610                 615                 620                 


Gly His Ser His Gly Ser Gln Glu Gly Gly Ala Asn Thr Thr Ser Gly 
625                 630                 635                 640 


Pro Ile Arg Thr Pro Gln Ile Pro Glu Trp Leu Ile Ile Leu Ala Ser 
                645                 650                 655     


Leu Leu Ala Leu Ala Leu Ile Leu Ala Val Cys Ile Ala Val Asn Ser 
            660                 665                 670         


Arg Arg Arg Cys Gly Gln Lys Lys Lys Leu Val Ile Asn Ser Gly Asn 
        675                 680                 685             


Gly Ala Val Glu Asp Arg Lys Pro Ser Gly Leu Asn Gly Glu Ala Ser 
    690                 695                 700                 


Lys Ser Gln Glu Met Val His Leu Val Asn Lys Glu Ser Ser Glu Thr 
705                 710                 715                 720 


Pro Asp Gln Phe Met Thr Ala Asp Glu Thr Arg Asn Leu Gln Asn Val 
                725                 730                 735     


Asp Met Lys Ile Gly Val 
            740         


<210>  329
<211>  6082
<212>  DNA
<213>  Homo sapiens

<400>  329
ataacgtctt tgtcactaaa atgttcccca ggggccttcg gcgagtcttt ttgtttggtt       60

ttttgttttt aatctgtggc tcttgataat ttatctagtg gttgcctaca cctgaaaaac      120

aagacacagt gtttaactat caacgaaaga actggacggc tccccgccgc agtcccactc      180

cccgagtttg tggctggcat ttgggccacg ccgggctggg cggtcacagc gaggggcgcg      240

cagtttgggg tcacacagct ccgcttctag gccccaacca ccgttaaaag gggaagcccg      300

tgccccatca ggtccgctct tgctgagccc agagccatcc cgcgctctgc gggctgggag      360

gcccgggcca ggacgcgagt cctgcgcagc cgaggttccc cagcgccccc tgcagccgcg      420

cgtaggcaga gacggagccc ggccctgcgc ctccgcacca cgcccgggac cccacccagc      480

ggcccgtacc cggagaagca gcgcgagcac ccgaagctcc cggctggcgg cagaaaccgg      540

gagtggggcc gggcgagtgc gcggcatccc aggccggccc gaacgctccg cccgcggtgg      600

gccgacttcc cctcctcttc cctctctcct tcctttagcc cgctggcgcc ggacacgctg      660

cgcctcatct cttggggcgt tcttccccgt tggccaaccg tcgcatcccg tgcaactttg      720

gggtagtggc cgtttagtgt tgaatgttcc ccaccgagag cgcatggctt gggaagcgag      780

gcgcgaaccc ggcccccgaa gggccgccgt ccgggagacg gtgatgctgt tgctgtgcct      840

gggggtcccg accggccgcc cctacaacgt ggacactgag agcgcgctgc tttaccaggg      900

cccccacaac acgctgttcg gctactcggt cgtgctgcac agccacgggg cgaaccgatg      960

gctcctagtg ggtgcgccca ctgccaactg gctcgccaac gcttcagtga tcaatcccgg     1020

ggcgatttac agatgcagga tcggaaagaa tcccggccag acgtgcgaac agctccagct     1080

gggtagccct aatggagaac cttgtggaaa gacttgtttg gaagagagag acaatcagtg     1140

gttgggggtc acactttcca gacagccagg agaaaatgga tccatcgtga cttgtgggca     1200

tagatggaaa aatatatttt acataaagaa tgaaaataag ctccccactg gtggttgcta     1260

tggagtgccc cctgatttac gaacagaact gagtaaaaga atagctccgt gttatcaaga     1320

ttatgtgaaa aaatttggag aaaattttgc atcatgtcaa gctggaatat ccagttttta     1380

cacaaaggat ttaattgtga tgggggcccc aggatcatct tactggactg gctctctttt     1440

tgtctacaat ataactacaa ataaatacaa ggctttttta gacaaacaaa atcaagtaaa     1500

atttggaagt tatttaggat attcagtcgg agctggtcat tttcggagcc agcatactac     1560

cgaagtagtc ggaggagctc ctcaacatga gcagattggt aaggcatata tattcagcat     1620

tgatgaaaaa gaactaaata tcttacatga aatgaaaggt aaaaagcttg gatcgtactt     1680

tggagcttct gtctgtgctg tggacctcaa tgcagatggc ttctcagatc tgctcgtggg     1740

agcacccatg cagagcacca tcagagagga aggaagagtg tttgtgtaca tcaactctgg     1800

ctcgggagca gtaatgaatg caatggaaac aaacctcgtt ggaagtgaca aatatgctgc     1860

aagatttggg gaatctatag ttaatcttgg cgacattgac aatgatggct ttgaagatgt     1920

tgctatcgga gctccacaag aagatgactt gcaaggtgct atttatattt acaatggccg     1980

tgcagatggg atctcgtcaa ccttctcaca gagaattgaa ggacttcaga tcagcaaatc     2040

gttaagtatg tttggacagt ctatatcagg acaaattgat gcagataata atggctatgt     2100

agatgtagca gttggtgctt ttcggtctga ttctgctgtc ttgctaagga caagacctgt     2160

agtaattgtt gacgcttctt taagccaccc tgagtcagta aatagaacga aatttgactg     2220

tgttgaaaat ggatggcctt ctgtgtgcat agatctaaca ctttgtttct catataaggg     2280

caaggaagtt ccaggttaca ttgttttgtt ttataacatg agtttggatg tgaacagaaa     2340

ggcagagtct ccaccaagat tctatttctc ttctaatgga acttctgacg tgattacagg     2400

aagcatacag gtgtccagca gagaagctaa ctgtagaaca catcaagcat ttatgcggaa     2460

agatgtgcgg gacatcctca ccccaattca gattgaagct gcttaccacc ttggtcctca     2520

tgtcatcagt aaacgaagta cagaggaatt cccaccactt cagccaattc ttcagcagaa     2580

gaaagaaaaa gacataatga aaaaaacaat aaactttgca aggttttgtg cccatgaaaa     2640

ttgttctgct gatttacagg tttctgcaaa gattgggttt ttgaagcccc atgaaaataa     2700

aacatatctt gctgttggga gtatgaagac attgatgttg aatgtgtcct tgtttaatgc     2760

tggagatgat gcatatgaaa cgactctaca tgtcaaacta cccgtgggtc tttatttcat     2820

taagatttta gagctggaag agaagcaaat aaactgtgaa gtcacagata actctggcgt     2880

ggtacaactt gactgcagta ttggctatat atatgtagat catctctcaa ggatagatat     2940

tagctttctc ctggatgtga gctcactcag cagagcggaa gaggacctca gtatcacagt     3000

gcatgctacc tgtgaaaatg aagaggaaat ggacaatcta aagcacagca gagtgactgt     3060

agcaatacct ttaaaatatg aggttaagct gactgttcat gggtttgtaa acccaacttc     3120

atttgtgtat ggatcaaatg atgaaaatga gcctgaaacg tgcatggtgg agaaaatgaa     3180

cttaactttc catgttatca acactggcaa tagtatggct cccaatgtta gtgtggaaat     3240

aatggtacca aattctttta gcccccaaac tgataagctg ttcaacattt tggatgtcca     3300

gactactact ggagaatgcc actttgaaaa ttatcaaaga gtgtgtgcat tagagcagca     3360

aaagagtgca atgcagacct tgaaaggcat agtccggttc ttgtccaaga ctgataagag     3420

gctattgtac tgcataaaag ctgatccaca ttgtttaaat ttcttgtgta attttgggaa     3480

aatggaaagt ggaaaagaag ccagtgttca tatccaactg gaaggccggc catccatttt     3540

agaaatggat gagacttcag cactcaagtt tgaaataaga gcaacaggtt ttccagagcc     3600

aaatccaaga gtaattgaac taaacaagga tgagaatgtt gcgcatgttc tactggaagg     3660

actacatcat caaagaccca aacgttattt caccatagtg attatttcaa gtagcttgct     3720

acttggactt attgtacttc tgttgatctc atatgttatg tggaaggctg gcttctttaa     3780

aagacaatac aaatctatcc tacaagaaga aaacagaaga gacagttgga gttatatcaa     3840

cagtaaaagc aatgatgatt aaggacttct ttcaaattga gagaatggaa aacagactca     3900

ggttgtagta aagaaattta aaagacactg tttacaagaa aaaatgaatt ttgtttggac     3960

ttcttttact catgatcttg tgacatatta tgtcttcatg caaggggaaa atctcagcaa     4020

tgattactct ttgagataga agaactgcaa aggtaataat acagccaaag ataatctctc     4080

agcttttaaa tgggtagaga aacactaaag cattcaattt attcaagaaa agtaagccct     4140

tgaagatatc ttgaaatgaa agtataactg agttaaatta tactggagaa gtcttagact     4200

tgaaatacta cttaccatat gtgcttgcct cagtaaaatg aaccccactg ggtgggcaga     4260

ggttcatttc aaatacatct ttgatacttg ttcaaaatat gttctttaaa aatataattt     4320

tttagagagc tgttcccaaa ttttctaacg agtggaccat tatcacttta aagcccttta     4380

tttataatac atttcctacg ggctgtgttc caacaaccat tttttttcag cagactatga     4440

atattatagt attataggcc aaactggcaa acttcagact gaacatgtac actggtttga     4500

gcttagtgaa attacttctg gataattatt tttttataat tatggatttc accatctttc     4560

tttctgtata tatacatgtg tttttatgta ggtatatatt taccattctt cctatctatt     4620

cttcctataa cacaccttta tcaagcatac ccaggagtaa tcttcaaatc ttttgttata     4680

ttctgaaaca aaagattgtg agtgttgcac tttacctgat acacgctgat ttagaaaata     4740

cagaaaccat acctcactaa taactttaaa atcaaagctg tgcaaagact agggggccta     4800

tacttcatat gtattatgta ctatgtaaaa tattgactat cacacaacta tttccttgga     4860

tgtaattctt tgttaccctt tacaagtata agtgttacct tacatggaaa cgaagaaaca     4920

aaattcataa atttaaattc ataaatttag ctgaaagata ctgattcaat ttgtatacag     4980

tgaatataaa tgagacgaca gcaaaatttt catgaaatgt aaaatatttt tatagtttgt     5040

tcatactata tgaggttcta ttttaaatga ctttctggat tttaaaaaat ttctttaaat     5100

acaatcattt ttgtaatatt tattttatgc ttatgatcta gataattgca gaatatcatt     5160

ttatctgact ctgccttcat aagagagctg tggccgaatt ttgaacatct gttataggga     5220

gtgatcaaat tagaaggcaa tgtggaaaaa caattctggg aaagatttct ttatatgaag     5280

tccctgccac tagccagcca tcctaattga tgaaagttat ctgttcacag gcctgcagtg     5340

atggtgagga atgttctgag atttgcgaag gcatttgagt agtgaaatgt aagcacaaaa     5400

cctcctgaac ccagagtgtg tatacacagg aataaacttt atgacattta tgtattttta     5460

aaaaactttg tatcgttata aaaaggctag tcattctttc aggagaacat ctaggatcat     5520

agatgaaaaa tcaagccccg atttagaact gtcttctcca ggatggtctc taaggaaatt     5580

tacatttggt tctttcctac tcagaactac tcagaaacaa ctatatattt caggttatct     5640

gagcacagtg aaagcagagt actatggttg tccaacacag gcctctcaga tacaagggga     5700

acacaattac atattgggct agattttgcc cagttcaaaa tagtatttgt tatcaactta     5760

ctttgttact tgtatcatga attttaaaac cctaccactt taagaagaca gggatgggtt     5820

attctttttt ggcaggtagg ctatataact atgtgatttt gaaatttaac tgctctggat     5880

tagggagcag tgaatcaagg cagacttatg aaatctgtat tatatttgta acagaatata     5940

ggaaatttaa cataattgat gagctcaaat cctgaaaaat gaaagaatcc aaattatttc     6000

agaattatct aggttaaata ttgatgtatt atgatggttg caaagttttt ttgtgtgtcc     6060

aataaacaca ttgtaaaaaa aa                                              6082


<210>  330
<211>  1032
<212>  PRT
<213>  Homo sapiens

<400>  330

Met Ala Trp Glu Ala Arg Arg Glu Pro Gly Pro Arg Arg Ala Ala Val 
1               5                   10                  15      


Arg Glu Thr Val Met Leu Leu Leu Cys Leu Gly Val Pro Thr Gly Arg 
            20                  25                  30          


Pro Tyr Asn Val Asp Thr Glu Ser Ala Leu Leu Tyr Gln Gly Pro His 
        35                  40                  45              


Asn Thr Leu Phe Gly Tyr Ser Val Val Leu His Ser His Gly Ala Asn 
    50                  55                  60                  


Arg Trp Leu Leu Val Gly Ala Pro Thr Ala Asn Trp Leu Ala Asn Ala 
65                  70                  75                  80  


Ser Val Ile Asn Pro Gly Ala Ile Tyr Arg Cys Arg Ile Gly Lys Asn 
                85                  90                  95      


Pro Gly Gln Thr Cys Glu Gln Leu Gln Leu Gly Ser Pro Asn Gly Glu 
            100                 105                 110         


Pro Cys Gly Lys Thr Cys Leu Glu Glu Arg Asp Asn Gln Trp Leu Gly 
        115                 120                 125             


Val Thr Leu Ser Arg Gln Pro Gly Glu Asn Gly Ser Ile Val Thr Cys 
    130                 135                 140                 


Gly His Arg Trp Lys Asn Ile Phe Tyr Ile Lys Asn Glu Asn Lys Leu 
145                 150                 155                 160 


Pro Thr Gly Gly Cys Tyr Gly Val Pro Pro Asp Leu Arg Thr Glu Leu 
                165                 170                 175     


Ser Lys Arg Ile Ala Pro Cys Tyr Gln Asp Tyr Val Lys Lys Phe Gly 
            180                 185                 190         


Glu Asn Phe Ala Ser Cys Gln Ala Gly Ile Ser Ser Phe Tyr Thr Lys 
        195                 200                 205             


Asp Leu Ile Val Met Gly Ala Pro Gly Ser Ser Tyr Trp Thr Gly Ser 
    210                 215                 220                 


Leu Phe Val Tyr Asn Ile Thr Thr Asn Lys Tyr Lys Ala Phe Leu Asp 
225                 230                 235                 240 


Lys Gln Asn Gln Val Lys Phe Gly Ser Tyr Leu Gly Tyr Ser Val Gly 
                245                 250                 255     


Ala Gly His Phe Arg Ser Gln His Thr Thr Glu Val Val Gly Gly Ala 
            260                 265                 270         


Pro Gln His Glu Gln Ile Gly Lys Ala Tyr Ile Phe Ser Ile Asp Glu 
        275                 280                 285             


Lys Glu Leu Asn Ile Leu His Glu Met Lys Gly Lys Lys Leu Gly Ser 
    290                 295                 300                 


Tyr Phe Gly Ala Ser Val Cys Ala Val Asp Leu Asn Ala Asp Gly Phe 
305                 310                 315                 320 


Ser Asp Leu Leu Val Gly Ala Pro Met Gln Ser Thr Ile Arg Glu Glu 
                325                 330                 335     


Gly Arg Val Phe Val Tyr Ile Asn Ser Gly Ser Gly Ala Val Met Asn 
            340                 345                 350         


Ala Met Glu Thr Asn Leu Val Gly Ser Asp Lys Tyr Ala Ala Arg Phe 
        355                 360                 365             


Gly Glu Ser Ile Val Asn Leu Gly Asp Ile Asp Asn Asp Gly Phe Glu 
    370                 375                 380                 


Asp Val Ala Ile Gly Ala Pro Gln Glu Asp Asp Leu Gln Gly Ala Ile 
385                 390                 395                 400 


Tyr Ile Tyr Asn Gly Arg Ala Asp Gly Ile Ser Ser Thr Phe Ser Gln 
                405                 410                 415     


Arg Ile Glu Gly Leu Gln Ile Ser Lys Ser Leu Ser Met Phe Gly Gln 
            420                 425                 430         


Ser Ile Ser Gly Gln Ile Asp Ala Asp Asn Asn Gly Tyr Val Asp Val 
        435                 440                 445             


Ala Val Gly Ala Phe Arg Ser Asp Ser Ala Val Leu Leu Arg Thr Arg 
    450                 455                 460                 


Pro Val Val Ile Val Asp Ala Ser Leu Ser His Pro Glu Ser Val Asn 
465                 470                 475                 480 


Arg Thr Lys Phe Asp Cys Val Glu Asn Gly Trp Pro Ser Val Cys Ile 
                485                 490                 495     


Asp Leu Thr Leu Cys Phe Ser Tyr Lys Gly Lys Glu Val Pro Gly Tyr 
            500                 505                 510         


Ile Val Leu Phe Tyr Asn Met Ser Leu Asp Val Asn Arg Lys Ala Glu 
        515                 520                 525             


Ser Pro Pro Arg Phe Tyr Phe Ser Ser Asn Gly Thr Ser Asp Val Ile 
    530                 535                 540                 


Thr Gly Ser Ile Gln Val Ser Ser Arg Glu Ala Asn Cys Arg Thr His 
545                 550                 555                 560 


Gln Ala Phe Met Arg Lys Asp Val Arg Asp Ile Leu Thr Pro Ile Gln 
                565                 570                 575     


Ile Glu Ala Ala Tyr His Leu Gly Pro His Val Ile Ser Lys Arg Ser 
            580                 585                 590         


Thr Glu Glu Phe Pro Pro Leu Gln Pro Ile Leu Gln Gln Lys Lys Glu 
        595                 600                 605             


Lys Asp Ile Met Lys Lys Thr Ile Asn Phe Ala Arg Phe Cys Ala His 
    610                 615                 620                 


Glu Asn Cys Ser Ala Asp Leu Gln Val Ser Ala Lys Ile Gly Phe Leu 
625                 630                 635                 640 


Lys Pro His Glu Asn Lys Thr Tyr Leu Ala Val Gly Ser Met Lys Thr 
                645                 650                 655     


Leu Met Leu Asn Val Ser Leu Phe Asn Ala Gly Asp Asp Ala Tyr Glu 
            660                 665                 670         


Thr Thr Leu His Val Lys Leu Pro Val Gly Leu Tyr Phe Ile Lys Ile 
        675                 680                 685             


Leu Glu Leu Glu Glu Lys Gln Ile Asn Cys Glu Val Thr Asp Asn Ser 
    690                 695                 700                 


Gly Val Val Gln Leu Asp Cys Ser Ile Gly Tyr Ile Tyr Val Asp His 
705                 710                 715                 720 


Leu Ser Arg Ile Asp Ile Ser Phe Leu Leu Asp Val Ser Ser Leu Ser 
                725                 730                 735     


Arg Ala Glu Glu Asp Leu Ser Ile Thr Val His Ala Thr Cys Glu Asn 
            740                 745                 750         


Glu Glu Glu Met Asp Asn Leu Lys His Ser Arg Val Thr Val Ala Ile 
        755                 760                 765             


Pro Leu Lys Tyr Glu Val Lys Leu Thr Val His Gly Phe Val Asn Pro 
    770                 775                 780                 


Thr Ser Phe Val Tyr Gly Ser Asn Asp Glu Asn Glu Pro Glu Thr Cys 
785                 790                 795                 800 


Met Val Glu Lys Met Asn Leu Thr Phe His Val Ile Asn Thr Gly Asn 
                805                 810                 815     


Ser Met Ala Pro Asn Val Ser Val Glu Ile Met Val Pro Asn Ser Phe 
            820                 825                 830         


Ser Pro Gln Thr Asp Lys Leu Phe Asn Ile Leu Asp Val Gln Thr Thr 
        835                 840                 845             


Thr Gly Glu Cys His Phe Glu Asn Tyr Gln Arg Val Cys Ala Leu Glu 
    850                 855                 860                 


Gln Gln Lys Ser Ala Met Gln Thr Leu Lys Gly Ile Val Arg Phe Leu 
865                 870                 875                 880 


Ser Lys Thr Asp Lys Arg Leu Leu Tyr Cys Ile Lys Ala Asp Pro His 
                885                 890                 895     


Cys Leu Asn Phe Leu Cys Asn Phe Gly Lys Met Glu Ser Gly Lys Glu 
            900                 905                 910         


Ala Ser Val His Ile Gln Leu Glu Gly Arg Pro Ser Ile Leu Glu Met 
        915                 920                 925             


Asp Glu Thr Ser Ala Leu Lys Phe Glu Ile Arg Ala Thr Gly Phe Pro 
    930                 935                 940                 


Glu Pro Asn Pro Arg Val Ile Glu Leu Asn Lys Asp Glu Asn Val Ala 
945                 950                 955                 960 


His Val Leu Leu Glu Gly Leu His His Gln Arg Pro Lys Arg Tyr Phe 
                965                 970                 975     


Thr Ile Val Ile Ile Ser Ser Ser Leu Leu Leu Gly Leu Ile Val Leu 
            980                 985                 990         


Leu Leu Ile Ser Tyr Val Met Trp  Lys Ala Gly Phe Phe  Lys Arg Gln 
        995                 1000                 1005             


Tyr Lys  Ser Ile Leu Gln Glu  Glu Asn Arg Arg Asp  Ser Trp Ser 
    1010                 1015                 1020             


Tyr Ile  Asn Ser Lys Ser Asn  Asp Asp 
    1025                 1030         


<210>  331
<211>  1586
<212>  DNA
<213>  Homo sapiens

<400>  331
ggttgtagga ccggcgagga ataggaatca tggcggctgc gctgttcgtg ctgctgggat       60

tcgcgctgct gggcacccac ggagcctccg gggctgccgg cacagtcttc actaccgtag      120

aagaccttgg ctccaagata ctcctcacct gctccttgaa tgacagcgcc acagaggtca      180

cagggcaccg ctggctgaag gggggcgtgg tgctgaagga ggacgcgctg cccggccaga      240

aaacggagtt caaggtggac tccgacgacc agtggggaga gtactcctgc gtcttcctcc      300

ccgagcccat gggcacggcc aacatccagc tccacgggcc tcccagagtg aaggccgtga      360

agtcgtcaga acacatcaac gagggggaga cggccatgct ggtctgcaag tcagagtccg      420

tgccacctgt cactgactgg gcctggtaca agatcactga ctctgaggac aaggccctca      480

tgaacggctc cgagagcagg ttcttcgtga gttcctcgca gggccggtca gagctacaca      540

ttgagaacct gaacatggag gccgaccccg gccagtaccg gtgcaacggc accagctcca      600

agggctccga ccaggccatc atcacgctcc gcgtgcgcag ccacctggcc gccctctggc      660

ccttcctggg catcgtggct gaggtgctgg tgctggtcac catcatcttc atctacgaga      720

agcgccggaa gcccgaggac gtcctggatg atgacgacgc cggctctgca cccctgaaga      780

gcagcgggca gcaccagaat gacaaaggca agaacgtccg ccagaggaac tcttcctgag      840

gcaggtggcc cgaggacgct ccctgctccg cgtctgcgcc gccgccggag tccactccca      900

gtgcttgcaa gattccaagt tctcacctct taaagaaaac ccaccccgta gattcccatc      960

atacacttcc ttctttttta aaaaagttgg gttttctcca ttcaggattc tgttccttag     1020

gattttttct tctgaagtgt ttcacgagag cccgggagct gctgccctgc ggccccgtct     1080

gtggctttca gcctctgggt ctgagtcatg gccgggtggg cggcacagcc ttctccactg     1140

gccggagtca gtgccaggtc cttgcccttt gtggaaagtc acaggtcaca cgaggggccc     1200

cgtgtcctgc ctgtctgaag ccaatgctgt ctggttgcgc catttttgtg cttttatgtt     1260

taattttatg agggccacgg gtctgtgttc gactcagcct cagggacgac tctgacctct     1320

tggccacaga ggactcactt gcccacaccg agggcgaccc cgtcacagcc tcaagtcact     1380

cccaagcccc ctccttgtct gtgcatccgg gggcagctct ggagggggtt tgctggggaa     1440

ctggcgccat cgccgggact ccagaaccgc agaagcctcc ccagctcacc cctggaggac     1500

ggccggctct ctatagcacc agggctcacg tgggaacccc cctcccaccc accgccacaa     1560

taaagatcgc ccccacctcc agggtc                                          1586


<210>  332
<211>  269
<212>  PRT
<213>  Homo sapiens

<400>  332

Met Ala Ala Ala Leu Phe Val Leu Leu Gly Phe Ala Leu Leu Gly Thr 
1               5                   10                  15      


His Gly Ala Ser Gly Ala Ala Gly Thr Val Phe Thr Thr Val Glu Asp 
            20                  25                  30          


Leu Gly Ser Lys Ile Leu Leu Thr Cys Ser Leu Asn Asp Ser Ala Thr 
        35                  40                  45              


Glu Val Thr Gly His Arg Trp Leu Lys Gly Gly Val Val Leu Lys Glu 
    50                  55                  60                  


Asp Ala Leu Pro Gly Gln Lys Thr Glu Phe Lys Val Asp Ser Asp Asp 
65                  70                  75                  80  


Gln Trp Gly Glu Tyr Ser Cys Val Phe Leu Pro Glu Pro Met Gly Thr 
                85                  90                  95      


Ala Asn Ile Gln Leu His Gly Pro Pro Arg Val Lys Ala Val Lys Ser 
            100                 105                 110         


Ser Glu His Ile Asn Glu Gly Glu Thr Ala Met Leu Val Cys Lys Ser 
        115                 120                 125             


Glu Ser Val Pro Pro Val Thr Asp Trp Ala Trp Tyr Lys Ile Thr Asp 
    130                 135                 140                 


Ser Glu Asp Lys Ala Leu Met Asn Gly Ser Glu Ser Arg Phe Phe Val 
145                 150                 155                 160 


Ser Ser Ser Gln Gly Arg Ser Glu Leu His Ile Glu Asn Leu Asn Met 
                165                 170                 175     


Glu Ala Asp Pro Gly Gln Tyr Arg Cys Asn Gly Thr Ser Ser Lys Gly 
            180                 185                 190         


Ser Asp Gln Ala Ile Ile Thr Leu Arg Val Arg Ser His Leu Ala Ala 
        195                 200                 205             


Leu Trp Pro Phe Leu Gly Ile Val Ala Glu Val Leu Val Leu Val Thr 
    210                 215                 220                 


Ile Ile Phe Ile Tyr Glu Lys Arg Arg Lys Pro Glu Asp Val Leu Asp 
225                 230                 235                 240 


Asp Asp Asp Ala Gly Ser Ala Pro Leu Lys Ser Ser Gly Gln His Gln 
                245                 250                 255     


Asn Asp Lys Gly Lys Asn Val Arg Gln Arg Asn Ser Ser 
            260                 265                 


<210>  333
<211>  3309
<212>  DNA
<213>  Homo sapiens

<400>  333
ttcagcccct ctcccgggct gcgcctccgc actccgggcc cgggcagaag ggggtgcgcc       60

tcggccccac cacccaggga gcagccgagc tgaaaggccg ggaaccgcgg cttgcgggga      120

ccacagctcc cgaaagcgac gttcggccac cggaggagcg ggagccaagc aggcggagct      180

cggcgggaga ggtgcgggcc gaatccgagc cgagcggaga ggaatccggc agtagagagc      240

ggactccagc cggcggaccc tgcagccctc gcctgggaca gcggcgcgct gggcaggcgc      300

ccaagagagc atcgagcagc ggaacccgcg aagccggccc gcagccgcga cccgcgcagc      360

ctgccgctct cccgccgccg gtccgggcag catgaggcgc gcggcgctct ggctctggct      420

gtgcgcgctg gcgctgagcc tgcagccggc cctgccgcaa attgtggcta ctaatttgcc      480

ccctgaagat caagatggct ctggggatga ctctgacaac ttctccggct caggtgcagg      540

tgctttgcaa gatatcacct tgtcacagca gaccccctcc acttggaagg acacgcagct      600

cctgacggct attcccacgt ctccagaacc caccggcctg gaggctacag ctgcctccac      660

ctccaccctg ccggctggag aggggcccaa ggagggagag gctgtagtcc tgccagaagt      720

ggagcctggc ctcaccgccc gggagcagga ggccaccccc cgacccaggg agaccacaca      780

gctcccgacc actcatcagg cctcaacgac cacagccacc acggcccagg agcccgccac      840

ctcccacccc cacagggaca tgcagcctgg ccaccatgag acctcaaccc ctgcaggacc      900

cagccaagct gaccttcaca ctccccacac agaggatgga ggtccttctg ccaccgagag      960

ggctgctgag gatggagcct ccagtcagct cccagcagca gagggctctg gggagcagga     1020

cttcaccttt gaaacctcgg gggagaatac ggctgtagtg gccgtggagc ctgaccgccg     1080

gaaccagtcc ccagtggatc agggggccac gggggcctca cagggcctcc tggacaggaa     1140

agaggtgctg ggaggggtca ttgccggagg cctcgtgggg ctcatctttg ctgtgtgcct     1200

ggtgggtttc atgctgtacc gcatgaagaa gaaggacgaa ggcagctact ccttggagga     1260

gccgaaacaa gccaacggcg gggcctacca gaagcccacc aaacaggagg aattctatgc     1320

ctgacgcggg agccatgcgc cccctccgcc ctgccactca ctaggccccc acttgcctct     1380

tccttgaaga actgcaggcc ctggcctccc ctgccaccag gccacctccc cagcattcca     1440

gcccctctgg tcgctcctgc ccacggagtc gtggggtgtg ctgggagctc cactctgctt     1500

ctctgacttc tgcctggaga cttagggcac caggggtttc tcgcatagga cctttccacc     1560

acagccagca cctggcatcg caccattctg actcggtttc tccaaactga agcagcctct     1620

ccccaggtcc agctctggag gggaggggga tccgactgct ttggacctaa atggcctcat     1680

gtggctggaa gatcctgcgg gtggggcttg gggctcacac acctgtagca cttactggta     1740

ggaccaagca tcttgggggg gtggccgctg agtggcaggg gacaggagtc cactttgttt     1800

cgtggggagg tctaatctag atatcgactt gtttttgcac atgtttcctc tagttctttg     1860

ttcatagccc agtagacctt gttacttctg aggtaagtta agtaagttga ttcggtatcc     1920

ccccatcttg cttccctaat ctatggtcgg gagacagcat cagggttaag aagacttttt     1980

tttttttttt ttaaactagg agaaccaaat ctggaagcca aaatgtaggc ttagtttgtg     2040

tgttgtctct tgagtttgtc gctcatgtgt gcaacagggt atggactatc tgtctggtgg     2100

ccccgtttct ggtggtctgt tggcaggctg gccagtccag gctgccgtgg ggccgccgcc     2160

tctttcaagc agtcgtgcct gtgtccatgc gctcagggcc atgctgaggc ctgggccgct     2220

gccacgttgg agaagcccgt gtgagaagtg aatgctggga ctcagccttc agacagagag     2280

gactgtaggg agggcggcag gggcctggag atcctcctgc agaccacgcc cgtcctgcct     2340

gtggcgccgt ctccaggggc tgcttcctcc tggaaattga cgaggggtgt cttgggcaga     2400

gctggctctg agcgcctcca tccaaggcca ggttctccgt tagctcctgt ggccccaccc     2460

tgggccctgg gctggaatca ggaatatttt ccaaagagtg atagtctttt gcttttggca     2520

aaactctact taatccaatg ggtttttccc tgtacagtag attttccaaa tgtaataaac     2580

tttaatataa agtagtcctg tgaatgccac tgccttcgct tcttgcctct gtgctgtgtg     2640

tgacgtgacc ggacttttct gcaaacacca acatgttggg aaacttggct cgaatctctg     2700

tgccttcgtc tttcccatgg ggagggattc tggttccagg gtccctctgt gtatttgctt     2760

ttttgttttg gctgaaattc tcctggaggt cggtaggttc agccaaggtt ttataaggct     2820

gatgtcaatt tctgtgttgc caagctccaa gccccatctt ctaaatggca aaggaaggtg     2880

gatggcccca gcacagcttg acctgaggct gtggtcacag cggaggtgtg gagccgaggc     2940

ctaccccgca gacaccttgg acatcctcct cccacccggc tgcagaggcc agaggccccc     3000

agcccagggc tcctgcactt acttgcttat ttgacaacgt ttcagcgact ccgttggcca     3060

ctccgagagg tgggccagtc tgtggatcag agatgcacca ccaagccaag ggaacctgtg     3120

tccggtattc gatactgcga ctttctgcct ggagtgtatg actgcacatg actcgggggt     3180

ggggaaaggg gtcggctgac catgctcatc tgctggtccg tgggacggtg cccaagccag     3240

aggctgggtt catttgtgta acgacaataa acggtacttg tcatttcggg caaaaaaaaa     3300

aaaaaaaaa                                                             3309


<210>  334
<211>  310
<212>  PRT
<213>  Homo sapiens

<400>  334

Met Arg Arg Ala Ala Leu Trp Leu Trp Leu Cys Ala Leu Ala Leu Ser 
1               5                   10                  15      


Leu Gln Pro Ala Leu Pro Gln Ile Val Ala Thr Asn Leu Pro Pro Glu 
            20                  25                  30          


Asp Gln Asp Gly Ser Gly Asp Asp Ser Asp Asn Phe Ser Gly Ser Gly 
        35                  40                  45              


Ala Gly Ala Leu Gln Asp Ile Thr Leu Ser Gln Gln Thr Pro Ser Thr 
    50                  55                  60                  


Trp Lys Asp Thr Gln Leu Leu Thr Ala Ile Pro Thr Ser Pro Glu Pro 
65                  70                  75                  80  


Thr Gly Leu Glu Ala Thr Ala Ala Ser Thr Ser Thr Leu Pro Ala Gly 
                85                  90                  95      


Glu Gly Pro Lys Glu Gly Glu Ala Val Val Leu Pro Glu Val Glu Pro 
            100                 105                 110         


Gly Leu Thr Ala Arg Glu Gln Glu Ala Thr Pro Arg Pro Arg Glu Thr 
        115                 120                 125             


Thr Gln Leu Pro Thr Thr His Gln Ala Ser Thr Thr Thr Ala Thr Thr 
    130                 135                 140                 


Ala Gln Glu Pro Ala Thr Ser His Pro His Arg Asp Met Gln Pro Gly 
145                 150                 155                 160 


His His Glu Thr Ser Thr Pro Ala Gly Pro Ser Gln Ala Asp Leu His 
                165                 170                 175     


Thr Pro His Thr Glu Asp Gly Gly Pro Ser Ala Thr Glu Arg Ala Ala 
            180                 185                 190         


Glu Asp Gly Ala Ser Ser Gln Leu Pro Ala Ala Glu Gly Ser Gly Glu 
        195                 200                 205             


Gln Asp Phe Thr Phe Glu Thr Ser Gly Glu Asn Thr Ala Val Val Ala 
    210                 215                 220                 


Val Glu Pro Asp Arg Arg Asn Gln Ser Pro Val Asp Gln Gly Ala Thr 
225                 230                 235                 240 


Gly Ala Ser Gln Gly Leu Leu Asp Arg Lys Glu Val Leu Gly Gly Val 
                245                 250                 255     


Ile Ala Val Gly Leu Val Gly Leu Ile Phe Ala Val Cys Leu Val Gly 
            260                 265                 270         


Phe Met Leu Tyr Arg Met Lys Lys Lys Asp Glu Gly Ser Tyr Ser Leu 
        275                 280                 285             


Glu Glu Pro Lys Gln Ala Asn Gly Gly Ala Tyr Gln Lys Pro Thr Lys 
    290                 295                 300                 


Gln Glu Glu Phe Tyr Ala 
305                 310 


<210>  335
<211>  5977
<212>  DNA
<213>  Homo sapiens

<400>  335
tgtctctctt acctccttga tgttcggcac tatttgtggc cggcgtggtg gaaggacaca       60

gtgaggttct cacccccgcc ccccgctcct cgctcccatc ccagttccat caaaacgaac      120

ccgggccagc gcaaggatct ccgagttgcg agtgtgctga ggctgggact gtcactcatt      180

ctccgatcag cgcgtgaacg cagctcggct gccgctggca ggaaacaatt ctgcaaaaat      240

aatcatactc agcctggcaa ttgtctgccc ctaggtctgt cgctcagccg ccgtccacac      300

tcgctgcagg ggggggggca cagaatttac cgcggcaaga acatccctcc cagccagcag      360

attacaatgc tgcaaactaa ggatctcatc tggactttgt ttttcctggg aactgcagtt      420

tctctgcagg tggatattgt tcccagccag ggggagatca gcgttggaga gtccaaattc      480

ttcttatgcc aagtggcagg agatgccaaa gataaagaca tctcctggtt ctcccccaat      540

ggagaaaagc tcaccccaaa ccagcagcgg atctcagtgg tgtggaatga tgattcctcc      600

tccaccctca ccatctataa cgccaacatc gacgacgccg gcatttacaa gtgtgtggtt      660

acaggcgagg atggcagtga gtcagaggcc accgtcaacg tgaagatctt tcagaagctc      720

atgttcaaga atgcgccaac cccacaggag ttccgggagg gggaagatgc cgtgattgtg      780

tgtgatgtgg tcagctccct cccaccaacc atcatctgga aacacaaagg ccgagatgtc      840

atcctgaaaa aagatgtccg attcatagtc ctgtccaaca actacctgca gatccggggc      900

atcaagaaaa cagatgaggg cacttatcgc tgtgagggca gaatcctggc acggggggag      960

atcaacttca aggacattca ggtcattgtg aatgtgccac ctaccatcca ggccaggcag     1020

aatattgtga atgccaccgc caacctcggc cagtccgtca ccctggtgtg cgatgccgaa     1080

ggcttcccag agcccaccat gagctggaca aaggatgggg aacagataga gcaagaggaa     1140

gacgatgaga agtacatctt cagcgacgat agttcccagc tgaccatcaa aaaggtggat     1200

aagaacgacg aggctgagta catctgcatt gctgagaaca aggctggcga gcaggatgcg     1260

accatccacc tcaaagtctt tgcaaaaccc aaaatcacat atgtagagaa ccagactgcc     1320

atggaattag aggagcaggt cactcttacc tgtgaagcct ccggagaccc cattccctcc     1380

atcacctgga ggacttctac ccggaacatc agcagcgaag aaaagactct ggatgggcac     1440

atggtggtgc gtagccatgc ccgtgtgtcg tcgctgaccc tgaagagcat ccagtacact     1500

gatgccggag agtacatctg caccgccagc aacaccatcg gccaggactc ccagtccatg     1560

taccttgaag tgcaatatgc cccaaagcta cagggccctg tggctgtgta cacttgggag     1620

gggaaccagg tgaacatcac ctgcgaggta tttgcctatc ccagtgccac gatctcatgg     1680

tttcgggatg gccagctgct gccaagctcc aattacagca atatcaagat ctacaacacc     1740

ccctctgcca gctatctgga ggtgacccca gactctgaga atgattttgg gaactacaac     1800

tgtactgcag tgaaccgcat tgggcaggag tccttggaat tcatccttgt tcaagcagac     1860

accccctctt caccatccat cgaccaggtg gagccatact ccagcacagc ccaggtgcag     1920

tttgatgaac cagaggccac aggtggggtg cccatcctca aatacaaagc tgagtggaga     1980

gcagttggtg aagaagtatg gcattccaag tggtatgatg ccaaggaagc cagcatggag     2040

ggcatcgtca ccatcgtggg cctgaagccc gaaacaacgt acgccgtaag gctggcggcg     2100

ctcaatggca aagggctggg tgagatcagc gcggcctccg agttcaagac gcagccagtc     2160

caaggggaac ccagtgcacc taagctcgaa gggcagatgg gagaggatgg aaactctatt     2220

aaagtgaacc tgatcaagca ggatgacggc ggctccccca tcagacacta tctggtcagg     2280

taccgagcgc tctcctccga gtggaaacca gagatcaggc tcccgtctgg cagtgaccac     2340

gtcatgctga agtccctgga ctggaatgct gagtatgagg tctacgtggt ggctgagaac     2400

cagcaaggaa aatccaaggc ggctcatttt gtgttcagga cctcggccca gcccacagcc     2460

atcccagcca acggcagccc cacctcaggc ctgagcaccg gggccatcgt gggcatcctc     2520

atcgtcatct tcgtcctgct cctggtggtt gtggacatca cctgctactt cctgaacaag     2580

tgtggcctgt tcatgtgcat tgcggtcaac ctgtgtggaa aagccgggcc cggggccaag     2640

ggcaaggaca tggaggaggg caaggccgcc ttctcgaaag atgagtccaa ggagcccatc     2700

gtggaggttc gaacggagga ggagaggacc ccaaaccatg atggagggaa acacacagag     2760

cccaacgaga ccacgccact gacggagccc gagaagggcc ccgtagaagc aaagccagag     2820

tgccaggaga cagaaacgaa gccagcgcca gccgaagtca agacggtccc caatgacgcc     2880

acacagacaa aggagaacga gagcaaagca tgatgggtga agagaaccga gcaaagatca     2940

aaataaaaag tgacacagca gcttcaccag agcatttcca acaccacaga cacacacacg     3000

cacgcacaca cacaaacaca catgcacaca cacacatctc atttctctag tgtcttttgc     3060

ctttaaaaaa aactaaacag ataaaacatg ggaatctcct ttttgtaggt ttatagaaag     3120

ggtccctttg ttgcacactc acttgtaaga aaatgagaca aaaaggttaa acccacagcc     3180

aaactaggac actccgttcc ctgaaaccgt taaaaaatca aacaaaagga ccccaaatta     3240

agaatctagg aagctcagaa acgaaatcta ggttcaggaa gaccacactt ggtgttaccc     3300

gattggcaca gaccagtttc agagaaatac tttcaggcac taagactaat cgaatgaaca     3360

aagtccacag tttattttta tactttcagt caagtttgaa ctctgtaaaa cctcataaat     3420

aagttataat ttctgttcac tttgtatttg ttcagtatgc aaagtgtgtc accctttcta     3480

gctgaattca attcccacgt agactcttat tttataggac gaatgccaaa ttgcagcttc     3540

tgggggtaga tctcaatttg cagtattcag acttcttttt ctttctttta cattcttttt     3600

tctttctttc tttctgccaa ctttgttttc cagtgtttac aaggtgacaa atgtttgact     3660

ttggttgtgt ttaaatgtcc gtgtaaaata gctgcctttt attttttaag gtaacaaata     3720

ccacctagag gtaggtagga tcatcccacg cttgctttag cacaggacaa ctttacaaaa     3780

catgattgtt tacagctgct cttcccctct tttctgatct gcagtttttg cctgggtccc     3840

actcaggtga aaatccatct cattctggaa tggttttgct tttgaatttt tggttatttt     3900

tgtgtttctt tgggggttag accactttct gattagccgc cacctgcctg catctgtgaa     3960

aagggatctg ctcccaggcg ttctcaccct tcttttgaag gactccttag gctttgttga     4020

atgaagcaga gaagattgta tagttggggc tggtcttggt gaacacacat tattacccca     4080

cacatcccct ttgtgtagaa agccaaataa aatctataca taccatttcc ttttgagccc     4140

agaatctaga tttgagcgga agagcatgtg tgcttcaggg aattagtgtc tttttttgga     4200

aatctgttga agtaaagtaa catcggcctt ctgttcactt aggcagcatt tatagaaaca     4260

aaagaagaaa gaaacaacct actgtctgga gtcataacac aactttcctg gattggaaac     4320

caagtggggg aaaaaataca gaaactttaa gggggatggg agggggggga gaagggaaaa     4380

gccagccctt tgtatagaaa ttttgctttt ttttccctca ttctacttta gaactgcaag     4440

cttgtgcact gtggatgcgt gaatatttta gtgtgaaacg tgtttttgtc atagtattga     4500

aataaaactt caacatagtt tggttgtgga aggtatagca gatagttcag aaaaaatatt     4560

caggaaacaa aaatcactca aacggaatcg aagcctttta acaaagaaaa tgaaatacag     4620

atgatgatga tgatgatgaa gatgatgcta agtaaacaga aatcagtact ccgcatgcgc     4680

tcctctccta aggtacaaag cagcaagagg ttagggtggc aaggctgcct ctgggtccat     4740

tctgtgggcc actctcccca acgttctgac acttctgcag tctgatcagt ggcgatgcta     4800

gattataatt tcaaactgtg aagaataatg gtcttgtcat ttgctcaatg tggggttatg     4860

ttgcattttc tcagctcctg gggatggaaa tggaggatcc cagaacacac agccctggcc     4920

cctttgattc tagggcctgc acagatctct ggttcaaatg cacaggccct cagaatagag     4980

gaacatgaag agagatctta gagcacacag tagaatgtga gagcctgggt gtctgagacc     5040

gggagggccc agcagtgagg ggcaggctct tctggtcacc aggctgttca gtggactcag     5100

ttcttcatct tgtaatgtcg atggctttgc cacaccaggc caagcccatg ccataccttg     5160

tcaagactgt caaagtggtt gtggttaggt caaactggtt ttggttctga tggttaggaa     5220

gaaacaggtc agccctcaga tcacctggcc cgggacagct gaccccctag aaccctggct     5280

ctgccattag ctaggaccta agactctgcc cacattttgg tctgttctct cccattacac     5340

ataggtttgt ctcagcatgc aagagttttt cctttaaaaa aaaaaaaaaa aaaaaaaaaa     5400

aagcaatgct ttctctaaaa tcaaagaggg agtcatttta ttccaagatg ttttatcttt     5460

tatgttaaga gatcaaagct tataattttc ttttttaatt tttgaaggag ggatcaactc     5520

cagtttccaa tgtctatgtg tctatgtgtg tatgtgccat acatatgtat tcacatgaag     5580

accggcatgg ccaagttctg ctggaggagc actcaagtgt gacgagcagg gccactggac     5640

cctgcagggc tgtggtgtat atagtgcagc tttggaggtg gaactctatt ttcacacttt     5700

tctatggagc cttccgagtc ccaggttttc acttgaggct gtctgtctgg atggcggttt     5760

tcagacctcc attaacatcc ctacccagca ttctgtactt cgggggcctt ctctcttgtt     5820

ataaaacttt ttaccaagtg aaacatcgat accacctttg tttccattct cactggtgta     5880

aatactgagt actaactgag aattttgact ttgcattctg tcggaatact tgtgttcaat     5940

aaaaattgaa agaaaaaagc taaaaaaaaa aaaaaaa                              5977


<210>  336
<211>  848
<212>  PRT
<213>  Homo sapiens

<400>  336

Met Leu Gln Thr Lys Asp Leu Ile Trp Thr Leu Phe Phe Leu Gly Thr 
1               5                   10                  15      


Ala Val Ser Leu Gln Val Asp Ile Val Pro Ser Gln Gly Glu Ile Ser 
            20                  25                  30          


Val Gly Glu Ser Lys Phe Phe Leu Cys Gln Val Ala Gly Asp Ala Lys 
        35                  40                  45              


Asp Lys Asp Ile Ser Trp Phe Ser Pro Asn Gly Glu Lys Leu Thr Pro 
    50                  55                  60                  


Asn Gln Gln Arg Ile Ser Val Val Trp Asn Asp Asp Ser Ser Ser Thr 
65                  70                  75                  80  


Leu Thr Ile Tyr Asn Ala Asn Ile Asp Asp Ala Gly Ile Tyr Lys Cys 
                85                  90                  95      


Val Val Thr Gly Glu Asp Gly Ser Glu Ser Glu Ala Thr Val Asn Val 
            100                 105                 110         


Lys Ile Phe Gln Lys Leu Met Phe Lys Asn Ala Pro Thr Pro Gln Glu 
        115                 120                 125             


Phe Arg Glu Gly Glu Asp Ala Val Ile Val Cys Asp Val Val Ser Ser 
    130                 135                 140                 


Leu Pro Pro Thr Ile Ile Trp Lys His Lys Gly Arg Asp Val Ile Leu 
145                 150                 155                 160 


Lys Lys Asp Val Arg Phe Ile Val Leu Ser Asn Asn Tyr Leu Gln Ile 
                165                 170                 175     


Arg Gly Ile Lys Lys Thr Asp Glu Gly Thr Tyr Arg Cys Glu Gly Arg 
            180                 185                 190         


Ile Leu Ala Arg Gly Glu Ile Asn Phe Lys Asp Ile Gln Val Ile Val 
        195                 200                 205             


Asn Val Pro Pro Thr Ile Gln Ala Arg Gln Asn Ile Val Asn Ala Thr 
    210                 215                 220                 


Ala Asn Leu Gly Gln Ser Val Thr Leu Val Cys Asp Ala Glu Gly Phe 
225                 230                 235                 240 


Pro Glu Pro Thr Met Ser Trp Thr Lys Asp Gly Glu Gln Ile Glu Gln 
                245                 250                 255     


Glu Glu Asp Asp Glu Lys Tyr Ile Phe Ser Asp Asp Ser Ser Gln Leu 
            260                 265                 270         


Thr Ile Lys Lys Val Asp Lys Asn Asp Glu Ala Glu Tyr Ile Cys Ile 
        275                 280                 285             


Ala Glu Asn Lys Ala Gly Glu Gln Asp Ala Thr Ile His Leu Lys Val 
    290                 295                 300                 


Phe Ala Lys Pro Lys Ile Thr Tyr Val Glu Asn Gln Thr Ala Met Glu 
305                 310                 315                 320 


Leu Glu Glu Gln Val Thr Leu Thr Cys Glu Ala Ser Gly Asp Pro Ile 
                325                 330                 335     


Pro Ser Ile Thr Trp Arg Thr Ser Thr Arg Asn Ile Ser Ser Glu Glu 
            340                 345                 350         


Lys Thr Leu Asp Gly His Met Val Val Arg Ser His Ala Arg Val Ser 
        355                 360                 365             


Ser Leu Thr Leu Lys Ser Ile Gln Tyr Thr Asp Ala Gly Glu Tyr Ile 
    370                 375                 380                 


Cys Thr Ala Ser Asn Thr Ile Gly Gln Asp Ser Gln Ser Met Tyr Leu 
385                 390                 395                 400 


Glu Val Gln Tyr Ala Pro Lys Leu Gln Gly Pro Val Ala Val Tyr Thr 
                405                 410                 415     


Trp Glu Gly Asn Gln Val Asn Ile Thr Cys Glu Val Phe Ala Tyr Pro 
            420                 425                 430         


Ser Ala Thr Ile Ser Trp Phe Arg Asp Gly Gln Leu Leu Pro Ser Ser 
        435                 440                 445             


Asn Tyr Ser Asn Ile Lys Ile Tyr Asn Thr Pro Ser Ala Ser Tyr Leu 
    450                 455                 460                 


Glu Val Thr Pro Asp Ser Glu Asn Asp Phe Gly Asn Tyr Asn Cys Thr 
465                 470                 475                 480 


Ala Val Asn Arg Ile Gly Gln Glu Ser Leu Glu Phe Ile Leu Val Gln 
                485                 490                 495     


Ala Asp Thr Pro Ser Ser Pro Ser Ile Asp Gln Val Glu Pro Tyr Ser 
            500                 505                 510         


Ser Thr Ala Gln Val Gln Phe Asp Glu Pro Glu Ala Thr Gly Gly Val 
        515                 520                 525             


Pro Ile Leu Lys Tyr Lys Ala Glu Trp Arg Ala Val Gly Glu Glu Val 
    530                 535                 540                 


Trp His Ser Lys Trp Tyr Asp Ala Lys Glu Ala Ser Met Glu Gly Ile 
545                 550                 555                 560 


Val Thr Ile Val Gly Leu Lys Pro Glu Thr Thr Tyr Ala Val Arg Leu 
                565                 570                 575     


Ala Ala Leu Asn Gly Lys Gly Leu Gly Glu Ile Ser Ala Ala Ser Glu 
            580                 585                 590         


Phe Lys Thr Gln Pro Val Gln Gly Glu Pro Ser Ala Pro Lys Leu Glu 
        595                 600                 605             


Gly Gln Met Gly Glu Asp Gly Asn Ser Ile Lys Val Asn Leu Ile Lys 
    610                 615                 620                 


Gln Asp Asp Gly Gly Ser Pro Ile Arg His Tyr Leu Val Arg Tyr Arg 
625                 630                 635                 640 


Ala Leu Ser Ser Glu Trp Lys Pro Glu Ile Arg Leu Pro Ser Gly Ser 
                645                 650                 655     


Asp His Val Met Leu Lys Ser Leu Asp Trp Asn Ala Glu Tyr Glu Val 
            660                 665                 670         


Tyr Val Val Ala Glu Asn Gln Gln Gly Lys Ser Lys Ala Ala His Phe 
        675                 680                 685             


Val Phe Arg Thr Ser Ala Gln Pro Thr Ala Ile Pro Ala Asn Gly Ser 
    690                 695                 700                 


Pro Thr Ser Gly Leu Ser Thr Gly Ala Ile Val Gly Ile Leu Ile Val 
705                 710                 715                 720 


Ile Phe Val Leu Leu Leu Val Val Val Asp Ile Thr Cys Tyr Phe Leu 
                725                 730                 735     


Asn Lys Cys Gly Leu Phe Met Cys Ile Ala Val Asn Leu Cys Gly Lys 
            740                 745                 750         


Ala Gly Pro Gly Ala Lys Gly Lys Asp Met Glu Glu Gly Lys Ala Ala 
        755                 760                 765             


Phe Ser Lys Asp Glu Ser Lys Glu Pro Ile Val Glu Val Arg Thr Glu 
    770                 775                 780                 


Glu Glu Arg Thr Pro Asn His Asp Gly Gly Lys His Thr Glu Pro Asn 
785                 790                 795                 800 


Glu Thr Thr Pro Leu Thr Glu Pro Glu Lys Gly Pro Val Glu Ala Lys 
                805                 810                 815     


Pro Glu Cys Gln Glu Thr Glu Thr Lys Pro Ala Pro Ala Glu Val Lys 
            820                 825                 830         


Thr Val Pro Asn Asp Ala Thr Gln Thr Lys Glu Asn Glu Ser Lys Ala 
        835                 840                 845             


<210>  337
<211>  3024
<212>  DNA
<213>  Homo sapiens

<400>  337
ctataaagga tcacgcgccc cagtcgacgc tgagctcctc tgctactcag agttgcaacc       60

tcagcctcgc tatggctccc agcagccccc ggcccgcgct gcccgcactc ctggtcctgc      120

tcggggctct gttcccagga cctggcaatg cccagacatc tgtgtccccc tcaaaagtca      180

tcctgccccg gggaggctcc gtgctggtga catgcagcac ctcctgtgac cagcccaagt      240

tgttgggcat agagaccccg ttgcctaaaa aggagttgct cctgcctggg aacaaccgga      300

aggtgtatga actgagcaat gtgcaagaag atagccaacc aatgtgctat tcaaactgcc      360

ctgatgggca gtcaacagct aaaaccttcc tcaccgtgta ctggactcca gaacgggtgg      420

aactggcacc cctcccctct tggcagccag tgggcaagaa ccttacccta cgctgccagg      480

tggagggtgg ggcaccccgg gccaacctca ccgtggtgct gctccgtggg gagaaggagc      540

tgaaacggga gccagctgtg ggggagcccg ctgaggtcac gaccacggtg ctggtgagga      600

gagatcacca tggagccaat ttctcgtgcc gcactgaact ggacctgcgg ccccaagggc      660

tggagctgtt tgagaacacc tcggccccct accagctcca gacctttgtc ctgccagcga      720

ctcccccaca acttgtcagc ccccgggtcc tagaggtgga cacgcagggg accgtggtct      780

gttccctgga cgggctgttc ccagtctcgg aggcccaggt ccacctggca ctgggggacc      840

agaggttgaa ccccacagtc acctatggca acgactcctt ctcggccaag gcctcagtca      900

gtgtgaccgc agaggacgag ggcacccagc ggctgacgtg tgcagtaata ctggggaacc      960

agagccagga gacactgcag acagtgacca tctacagctt tccggcgccc aacgtgattc     1020

tgacgaagcc agaggtctca gaagggaccg aggtgacagt gaagtgtgag gcccacccta     1080

gagccaaggt gacgctgaat ggggttccag cccagccact gggcccgagg gcccagctcc     1140

tgctgaaggc caccccagag gacaacgggc gcagcttctc ctgctctgca accctggagg     1200

tggccggcca gcttatacac aagaaccaga cccgggagct tcgtgtcctg tatggccccc     1260

gactggacga gagggattgt ccgggaaact ggacgtggcc agaaaattcc cagcagactc     1320

caatgtgcca ggcttggggg aacccattgc ccgagctcaa gtgtctaaag gatggcactt     1380

tcccactgcc catcggggaa tcagtgactg tcactcgaga tcttgagggc acctacctct     1440

gtcgggccag gagcactcaa ggggaggtca cccgcaaggt gaccgtgaat gtgctctccc     1500

cccggtatga gattgtcatc atcactgtgg tagcagccgc agtcataatg ggcactgcag     1560

gcctcagcac gtacctctat aaccgccagc ggaagatcaa gaaatacaga ctacaacagg     1620

cccaaaaagg gacccccatg aaaccgaaca cacaagccac gcctccctga acctatcccg     1680

ggacagggcc tcttcctcgg ccttcccata ttggtggcag tggtgccaca ctgaacagag     1740

tggaagacat atgccatgca gctacaccta ccggccctgg gacgccggag gacagggcat     1800

tgtcctcagt cagatacaac agcatttggg gccatggtac ctgcacacct aaaacactag     1860

gccacgcatc tgatctgtag tcacatgact aagccaagag gaaggagcaa gactcaagac     1920

atgattgatg gatgttaaag tctagcctga tgagagggga agtggtgggg gagacatagc     1980

cccaccatga ggacatacaa ctgggaaata ctgaaacttg ctgcctattg ggtatgctga     2040

ggccccacag acttacagaa gaagtggccc tccatagaca tgtgtagcat caaaacacaa     2100

aggcccacac ttcctgacgg atgccagctt gggcactgct gtctactgac cccaaccctt     2160

gatgatatgt atttattcat ttgttatttt accagctatt tattgagtgt cttttatgta     2220

ggctaaatga acataggtct ctggcctcac ggagctccca gtcctaatca cattcaaggt     2280

caccaggtac agttgtacag gttgtacact gcaggagagt gcctggcaaa aagatcaaat     2340

ggggctggga cttctcattg gccaacctgc ctttccccag aaggagtgat ttttctatcg     2400

gcacaaaagc actatatgga ctggtaatgg ttacaggttc agagattacc cagtgaggcc     2460

ttattcctcc cttcccccca aaactgacac ctttgttagc cacctcccca cccacataca     2520

tttctgccag tgttcacaat gacactcagc ggtcatgtct ggacatgagt gcccagggaa     2580

tatgcccaag ctatgccttg tcctcttgtc ctgtttgcat ttcactggga gcttgcacta     2640

tgcagctcca gtttcctgca gtgatcaggg tcctgcaagc agtggggaag ggggccaagg     2700

tattggagga ctccctccca gctttggaag cctcatccgc gtgtgtgtgt gtgtgtatgt     2760

gtagacaagc tctcgctctg tcacccaggc tggagtgcag tggtgcaatc atggttcact     2820

gcagtcttga ccttttgagc tcaagtgatc ctcccacctc agcctcctga gtagctggga     2880

ccataggctc acaacaccac acctggcaaa tttgattttt tttttttttc cagagacggg     2940

gtcttgcaac attgcccaga cttcctttgt gttagttaat aaagctttct caactgccaa     3000

aaaaaaaaaa aaaaaaaaaa aaaa                                            3024


<210>  338
<211>  532
<212>  PRT
<213>  Homo sapiens

<400>  338

Met Ala Pro Ser Ser Pro Arg Pro Ala Leu Pro Ala Leu Leu Val Leu 
1               5                   10                  15      


Leu Gly Ala Leu Phe Pro Gly Pro Gly Asn Ala Gln Thr Ser Val Ser 
            20                  25                  30          


Pro Ser Lys Val Ile Leu Pro Arg Gly Gly Ser Val Leu Val Thr Cys 
        35                  40                  45              


Ser Thr Ser Cys Asp Gln Pro Lys Leu Leu Gly Ile Glu Thr Pro Leu 
    50                  55                  60                  


Pro Lys Lys Glu Leu Leu Leu Pro Gly Asn Asn Arg Lys Val Tyr Glu 
65                  70                  75                  80  


Leu Ser Asn Val Gln Glu Asp Ser Gln Pro Met Cys Tyr Ser Asn Cys 
                85                  90                  95      


Pro Asp Gly Gln Ser Thr Ala Lys Thr Phe Leu Thr Val Tyr Trp Thr 
            100                 105                 110         


Pro Glu Arg Val Glu Leu Ala Pro Leu Pro Ser Trp Gln Pro Val Gly 
        115                 120                 125             


Lys Asn Leu Thr Leu Arg Cys Gln Val Glu Gly Gly Ala Pro Arg Ala 
    130                 135                 140                 


Asn Leu Thr Val Val Leu Leu Arg Gly Glu Lys Glu Leu Lys Arg Glu 
145                 150                 155                 160 


Pro Ala Val Gly Glu Pro Ala Glu Val Thr Thr Thr Val Leu Val Arg 
                165                 170                 175     


Arg Asp His His Gly Ala Asn Phe Ser Cys Arg Thr Glu Leu Asp Leu 
            180                 185                 190         


Arg Pro Gln Gly Leu Glu Leu Phe Glu Asn Thr Ser Ala Pro Tyr Gln 
        195                 200                 205             


Leu Gln Thr Phe Val Leu Pro Ala Thr Pro Pro Gln Leu Val Ser Pro 
    210                 215                 220                 


Arg Val Leu Glu Val Asp Thr Gln Gly Thr Val Val Cys Ser Leu Asp 
225                 230                 235                 240 


Gly Leu Phe Pro Val Ser Glu Ala Gln Val His Leu Ala Leu Gly Asp 
                245                 250                 255     


Gln Arg Leu Asn Pro Thr Val Thr Tyr Gly Asn Asp Ser Phe Ser Ala 
            260                 265                 270         


Lys Ala Ser Val Ser Val Thr Ala Glu Asp Glu Gly Thr Gln Arg Leu 
        275                 280                 285             


Thr Cys Ala Val Ile Leu Gly Asn Gln Ser Gln Glu Thr Leu Gln Thr 
    290                 295                 300                 


Val Thr Ile Tyr Ser Phe Pro Ala Pro Asn Val Ile Leu Thr Lys Pro 
305                 310                 315                 320 


Glu Val Ser Glu Gly Thr Glu Val Thr Val Lys Cys Glu Ala His Pro 
                325                 330                 335     


Arg Ala Lys Val Thr Leu Asn Gly Val Pro Ala Gln Pro Leu Gly Pro 
            340                 345                 350         


Arg Ala Gln Leu Leu Leu Lys Ala Thr Pro Glu Asp Asn Gly Arg Ser 
        355                 360                 365             


Phe Ser Cys Ser Ala Thr Leu Glu Val Ala Gly Gln Leu Ile His Lys 
    370                 375                 380                 


Asn Gln Thr Arg Glu Leu Arg Val Leu Tyr Gly Pro Arg Leu Asp Glu 
385                 390                 395                 400 


Arg Asp Cys Pro Gly Asn Trp Thr Trp Pro Glu Asn Ser Gln Gln Thr 
                405                 410                 415     


Pro Met Cys Gln Ala Trp Gly Asn Pro Leu Pro Glu Leu Lys Cys Leu 
            420                 425                 430         


Lys Asp Gly Thr Phe Pro Leu Pro Ile Gly Glu Ser Val Thr Val Thr 
        435                 440                 445             


Arg Asp Leu Glu Gly Thr Tyr Leu Cys Arg Ala Arg Ser Thr Gln Gly 
    450                 455                 460                 


Glu Val Thr Arg Lys Val Thr Val Asn Val Leu Ser Pro Arg Tyr Glu 
465                 470                 475                 480 


Ile Val Ile Ile Thr Val Val Ala Ala Ala Val Ile Met Gly Thr Ala 
                485                 490                 495     


Gly Leu Ser Thr Tyr Leu Tyr Asn Arg Gln Arg Lys Ile Lys Lys Tyr 
            500                 505                 510         


Arg Leu Gln Gln Ala Gln Lys Gly Thr Pro Met Lys Pro Asn Thr Gln 
        515                 520                 525             


Ala Thr Pro Pro 
    530         


<210>  339
<211>  1796
<212>  DNA
<213>  Homo sapiens

<400>  339
ccttttcccc tgcctgccct tcgggcacct caggaaggca ccttcctctg tcagaatggc       60

caccatggta ccatccgtgt tgtggcccag ggcctgctgg actctgctgg tctgctgtct      120

gctgacccca ggtgtccagg ggcaggagtt ccttttgcgg gtggagcccc agaaccctgt      180

gctctctgct ggagggtccc tgtttgtgaa ctgcagtact gattgtccca gctctgagaa      240

aatcgccttg gagacgtccc tatcaaagga gctggtggcc agtggcatgg gctgggcagc      300

cttcaatctc agcaacgtga ctggcaacag tcggatcctc tgctcagtgt actgcaatgg      360

ctctcagata acaggctcct ctaacatcac cgtgtacagg ctcccggagc gtgtggagct      420

ggcacccctg cctccttggc agccggtggg ccagaacttc accctgcgct gccaagtgga      480

ggatgggtcg ccccggacca gcctcacggt ggtgctgctt cgctgggagg aggagctgag      540

ccggcagccc gcagtggagg agccagcgga ggtcactgcc actgtgctgg ccagcagaga      600

cgaccacgga gcccctttct catgccgcac agaactggac atgcagcccc aggggctggg      660

actgttcgtg aacacctcag ccccccgcca gctccgaacc tttgtcctgc ccgtgacccc      720

cccgcgcctc gtggcccccc ggttcttgga ggtggaaacg tcgtggccgg tggactgcac      780

cctagacggg ctttttccag cctcagaggc ccaggtctac ctggcgctgg gggaccagat      840

gctgaatgcg acagtcatga accacgggga cacgctaacg gccacagcca cagccacggc      900

gcgcgcggat caggagggtg cccgggagat cgtctgcaac gtgaccctag ggggcgagag      960

acgggaggcc cgggagaact tgacggtctt tagcttccta ggacccattg tgaacctcag     1020

cgagcccacc gcccatgagg ggtccacagt gaccgtgagt tgcatggctg gggctcgagt     1080

ccaggtcacg ctggacggag ttccggccgc ggccccgggg cagccagctc aacttcagct     1140

aaatgctacc gagagtgacg acggacgcag cttcttctgc agtgccactc tcgaggtgga     1200

cggcgagttc ttgcacagga acagtagcgt ccagctgcga gtcctgtatg gtcccaaaat     1260

tgaccgagcc acatgccccc agcacttgaa atggaaagat aaaacgagac acgtcctgca     1320

gtgccaagcc aggggcaacc cgtaccccga gctgcggtgt ttgaaggaag gctccagccg     1380

ggaggtgccg gtggggatcc cgttcttcgt caacgtaaca cataatggta cttatcagtg     1440

ccaagcgtcc agctcacgag gcaaatacac cctggtcgtg gtgatggaca ttgaggctgg     1500

gagctcccac tttgtccccg tcttcgtggc ggtgttactg accctgggcg tggtgactat     1560

cgtactggcc ttaatgtacg tcttcaggga gcaccaacgg agcggcagtt accatgttag     1620

ggaggagagc acctatctgc ccctcacgtc tatgcagccg acagaagcaa tgggggaaga     1680

accgtccaga gctgagtgac gctgggatcc gggatcaaag ttggcggggg cttggctgtg     1740

ccctcagatt ccgcaccaat aaagccttca aactccctaa aaaaaaaaaa aaaaaa         1796


<210>  340
<211>  547
<212>  PRT
<213>  Homo sapiens

<400>  340

Met Ala Thr Met Val Pro Ser Val Leu Trp Pro Arg Ala Cys Trp Thr 
1               5                   10                  15      


Leu Leu Val Cys Cys Leu Leu Thr Pro Gly Val Gln Gly Gln Glu Phe 
            20                  25                  30          


Leu Leu Arg Val Glu Pro Gln Asn Pro Val Leu Ser Ala Gly Gly Ser 
        35                  40                  45              


Leu Phe Val Asn Cys Ser Thr Asp Cys Pro Ser Ser Glu Lys Ile Ala 
    50                  55                  60                  


Leu Glu Thr Ser Leu Ser Lys Glu Leu Val Ala Ser Gly Met Gly Trp 
65                  70                  75                  80  


Ala Ala Phe Asn Leu Ser Asn Val Thr Gly Asn Ser Arg Ile Leu Cys 
                85                  90                  95      


Ser Val Tyr Cys Asn Gly Ser Gln Ile Thr Gly Ser Ser Asn Ile Thr 
            100                 105                 110         


Val Tyr Arg Leu Pro Glu Arg Val Glu Leu Ala Pro Leu Pro Pro Trp 
        115                 120                 125             


Gln Pro Val Gly Gln Asn Phe Thr Leu Arg Cys Gln Val Glu Asp Gly 
    130                 135                 140                 


Ser Pro Arg Thr Ser Leu Thr Val Val Leu Leu Arg Trp Glu Glu Glu 
145                 150                 155                 160 


Leu Ser Arg Gln Pro Ala Val Glu Glu Pro Ala Glu Val Thr Ala Thr 
                165                 170                 175     


Val Leu Ala Ser Arg Asp Asp His Gly Ala Pro Phe Ser Cys Arg Thr 
            180                 185                 190         


Glu Leu Asp Met Gln Pro Gln Gly Leu Gly Leu Phe Val Asn Thr Ser 
        195                 200                 205             


Ala Pro Arg Gln Leu Arg Thr Phe Val Leu Pro Val Thr Pro Pro Arg 
    210                 215                 220                 


Leu Val Ala Pro Arg Phe Leu Glu Val Glu Thr Ser Trp Pro Val Asp 
225                 230                 235                 240 


Cys Thr Leu Asp Gly Leu Phe Pro Ala Ser Glu Ala Gln Val Tyr Leu 
                245                 250                 255     


Ala Leu Gly Asp Gln Met Leu Asn Ala Thr Val Met Asn His Gly Asp 
            260                 265                 270         


Thr Leu Thr Ala Thr Ala Thr Ala Thr Ala Arg Ala Asp Gln Glu Gly 
        275                 280                 285             


Ala Arg Glu Ile Val Cys Asn Val Thr Leu Gly Gly Glu Arg Arg Glu 
    290                 295                 300                 


Ala Arg Glu Asn Leu Thr Val Phe Ser Phe Leu Gly Pro Ile Val Asn 
305                 310                 315                 320 


Leu Ser Glu Pro Thr Ala His Glu Gly Ser Thr Val Thr Val Ser Cys 
                325                 330                 335     


Met Ala Gly Ala Arg Val Gln Val Thr Leu Asp Gly Val Pro Ala Ala 
            340                 345                 350         


Ala Pro Gly Gln Pro Ala Gln Leu Gln Leu Asn Ala Thr Glu Ser Asp 
        355                 360                 365             


Asp Gly Arg Ser Phe Phe Cys Ser Ala Thr Leu Glu Val Asp Gly Glu 
    370                 375                 380                 


Phe Leu His Arg Asn Ser Ser Val Gln Leu Arg Val Leu Tyr Gly Pro 
385                 390                 395                 400 


Lys Ile Asp Arg Ala Thr Cys Pro Gln His Leu Lys Trp Lys Asp Lys 
                405                 410                 415     


Thr Arg His Val Leu Gln Cys Gln Ala Arg Gly Asn Pro Tyr Pro Glu 
            420                 425                 430         


Leu Arg Cys Leu Lys Glu Gly Ser Ser Arg Glu Val Pro Val Gly Ile 
        435                 440                 445             


Pro Phe Phe Val Asn Val Thr His Asn Gly Thr Tyr Gln Cys Gln Ala 
    450                 455                 460                 


Ser Ser Ser Arg Gly Lys Tyr Thr Leu Val Val Val Met Asp Ile Glu 
465                 470                 475                 480 


Ala Gly Ser Ser His Phe Val Pro Val Phe Val Ala Val Leu Leu Thr 
                485                 490                 495     


Leu Gly Val Val Thr Ile Val Leu Ala Leu Met Tyr Val Phe Arg Glu 
            500                 505                 510         


His Gln Arg Ser Gly Ser Tyr His Val Arg Glu Glu Ser Thr Tyr Leu 
        515                 520                 525             


Pro Leu Thr Ser Met Gln Pro Thr Glu Ala Met Gly Glu Glu Pro Ser 
    530                 535                 540                 


Arg Ala Glu 
545         


<210>  341
<211>  7796
<212>  DNA
<213>  Homo sapiens

<400>  341
ggggccgggg ggcggagcct tgcgggctgg agcgaaagaa tgcgggggct gagcgcagaa       60

gcggctcgag gctggaagag gatcttgggc gccgccagtc tctctctgtt gcccaagctg      120

gagtgcagtg gcacagtctt ggctcactgc aacctccacc tcctgggtgc aagcgattct      180

cgtgtctcag cctctcaagt agctgggatt acagtcttta gcaccagttg gtgtaggagt      240

tgagacctac ttcacagtag ttctgtggac aatcacaatg ggaatccaag gagggtctgt      300

cctgttcggg ctgctgctcg tcctggctgt cttctgccat tcaggtcata gcctgcagtg      360

ctacaactgt cctaacccaa ctgctgactg caaaacagcc gtcaattgtt catctgattt      420

tgatgcgtgt ctcattacca aagctgggtt acaagtgtat aacaagtgtt ggaagtttga      480

gcattgcaat ttcaacgacg tcacaacccg cttgagggaa aatgagctaa cgtactactg      540

ctgcaagaag gacctgtgta actttaacga acagcttgaa aatggtggga catccttatc      600

agagaaaaca gttcttctgc tggtgactcc atttctggca gcagcctgga gccttcatcc      660

ctaagtcaac accaggagag cttctcccaa actccccgtt cctgcgtagt ccgctttctc      720

ttgctgccac attctaaagg cttgatattt tccaaatgga tcctgttggg aaagaataaa      780

attagcttga gcaacctggc taagatagag gggctctggg agactttgaa gaccagtcct      840

gtttgcaggg aagccccact tgaaggaaga agtctaagag tgaagtaggt gtgacttgaa      900

ctagattgca tgcttcctcc tttgctcttg ggaagaccag ctttgcagtg acagcttgag      960

tgggttctct gcagccctca gattattttt cctctggctc cttggatgta gtcagttagc     1020

atcattagta catctttgga gggtggggca ggagtatatg agcatcctct ctcacatgga     1080

acgctttcat aaacttcagg gatcccgtgt tgccatggag gcatgccaaa tgttccatat     1140

gtgggtgtca gtcagggaca acaagatcct taatgcagag ctagaggact tctggcaggg     1200

aagtggggaa gtgttccaga tagcagggca tgaaaactta gagaggtaca agtggctgaa     1260

aatcgagttt ttcctctgtc tttaaatttt atatgggctt tgttatcttc cactggaaaa     1320

gtgtaatagc atacatcaat ggtgtgttaa agctatttcc ttgccttttt tttattggaa     1380

tggtaggata tcttggcttt gccacacaca gttacagagt gaacactcta ctacatgtga     1440

ctggcagtat taagtgtgct tattttaaat gttactggta gaaaggcagt tcaggtatgt     1500

gtgtatatag tatgaatgca gtggggacac cctttgtggt tacagtttga gacttccaaa     1560

ggtcatcctt aataacaaca gatctgcagg ggtatgtttt accatctgca tccagcctcc     1620

tgctaactcc tagctgactc agcatagatt gtataaaata cctttgtaac ggctcttagc     1680

acactcacag atgtttgagg ctttcagaag ctcttctaaa aaatgataca cacctttcac     1740

aagggcaaac tttttccttt tccctgtgta ttctagtgaa tgaatctcaa gattcagtag     1800

acctaatgac atttgtattt tatgatcttg gctgtattta atggcatagg ctgacttttg     1860

cagatggagg aatttcttga ttaatgttga aaaaaaaccc ttgattatac tctgttggac     1920

aaaccgagtg caatgaatga tgcttttctg aaaatgaaat ataacaagtg ggtgaatgtg     1980

gttatggccg aaaaggatat gcagtatgct taatggtagc aactgaaaga agacatcctg     2040

agcagtgcca gctttcttct gttgatgccg ttccctgaac ataggaaaat agaaacttgc     2100

ttatcaaaac ttagcattac cttggtgctc tgtgttctct gttagctcag tgtctttcct     2160

tacatcaata ggtttttttt tttttttttg gcctgaggaa gtactgacca tgcccacagc     2220

caccggctga gcaaagaagc tcatttcatg tgagttctaa ggaatgagaa acaattttga     2280

tgaatttaag cagaaaatga atttctggga acttttttgg gggcgggggg gtggggaatt     2340

cagccacact ccagaaagcc aggagtcgac agttttggaa gcctctctca ggattgagat     2400

tctaggatga gattggctta ctgctatctt gtgtcatgta cccacttttt ggccagacta     2460

cactgggaag aaggtagtcc tctaaagcaa aatctgagtg ccactaaatg gggagatggg     2520

gctgttaagc tgtccaaatc aacaagggtc atataaatgg ccttaaactt tggggttgct     2580

ttctgcaaaa agttgctgtg actcatgcca tagacaaggt tgagtgcctg gacccaaagg     2640

caatactgta atgtaaagac atttatagta ctaggcaaac agcaccccag gtactccagg     2700

ccctcctggc tggagagggc tgtggcaata gaaaattagt gccaactgca gtgagtcagc     2760

ctaggttaaa tagagagtgt aagagtgctg gacaggaacc tccaccctca tgtcacattt     2820

cttcaatgtg acccttctgg cccctctcct cctgacagcg gaacaatgac tgccccgata     2880

ggtgaggctg gaggaagaat cagtcctgtc cttggcaagc tcttcactat gacagtaaag     2940

gctctctgcc tgctgccaag gcctgtgact ttctaacctg gcctcacgct gggtaagctt     3000

aaggtagagg tgcaggatta gcaagcccac ctggctacca ggccgacagc tacatcctcc     3060

aactgaccct gatcaacgaa gagggattca tgtgtctgtc tcagttggtt ccaaatgaaa     3120

ccagggagca ggggagttag gaatcgaaca ccagtcatgc ctactggctc tctgctcgag     3180

agccaatacc ctgtgccctc cactcatctg gatttacagg aactgtcata gtgttcagta     3240

ttgggtggtg ataagcccat tggattgtcc ccttgggggg atgagctagg ggtgcaagga     3300

acacctgatg agtagataag tggagctcat ggtatttcct gaaagatgct aatctatttg     3360

ccaaacttgg tcttgaatgt actgggggct tcaaggtatg ggtatatttt tcttgtgtcc     3420

ttgcagttag cccccatgtc ttatgtgtgt cctgaaaaaa taagagcctg cccaagactt     3480

tgggcctctt gacagaatta accactttta tacatctgag ttctcttggt aagttcttta     3540

gcagtgttca aagtctacta gctcgcatta gtttctgttg ctgccaacag atctgaacta     3600

atgctaacag atccccctga gggattcttg atgggctgag cagctggctg gagctagtac     3660

tgactgacat tcattgtgat gagggcagct ttctggtaca ggattctaag ctctatgttt     3720

tatatacatt ttcatctgta cttgcacctc actttacaca agaggaaact atgcaaagtt     3780

agctggatcg ctcaaggtca cttaggtaag ttggcaagtc catgcttccc actcagctcc     3840

tcaggtcagc aagtctactt ctctgcctat tttgtatact ctctttaata tgtgcctagc     3900

tttggaaagt ctagaatggg tccctggtgc ctttttactt tgaagaaatc agtttctgcc     3960

tctttttgga aaagaaaaca aagtgcaatt gttttttact ggaaagttac ccaatagcat     4020

gaggtgaaca ggacgtagtt aggccttcct gtaaacagaa aatcatatca aaacactatc     4080

ttcccatctg tttctcaatg cctgctactt cttgtagata tttcatttca ggagagcagc     4140

agttaaaccc gtggattttg tagttaggaa cctgggttca aaccctcttc cactaattgg     4200

ctatgtctct ggacaagttt tttttttttt ttttttttaa accctttctg aactttcact     4260

ttctatgtct acctcaaaga attgttgtga ggcttgagat aatgcatttg taaagggtct     4320

gccagatagg aagatgctag ttatggattt acaaggttgt taaggctgta agagtctaaa     4380

acctacagtg aatcacaatg catttacccc cactgacttg gacataagtg aaaactagcc     4440

agaagtctct ttttcaaatt acttacaggt tattcaatat aaaatttttg taatggataa     4500

tcttatttat ctaaactaaa gcttcctgtt tatacacact cctgttattc tgggataaga     4560

taaatgacca cagtacctta atttctaggt gggtgcctgt gatggttcat tgtaggtaag     4620

gacattttct ctttttcagc agctgtgtag gtccagagcc tctgggagag gaggggggta     4680

gcatgcaccc agcaggggac tgaactggga aactcaaggt tctttttact gtggggtagt     4740

gagctgcctt tctgtgatcg gtttccctag ggatgttgct gttcccctcc ttgctattcg     4800

cagctacata caacgtggcc aaccccagta ggctgatcct atatatgatc agtgctggtg     4860

ctgactctca atagccccac ccaagctggc tataggttta cagatacatt aattaggcaa     4920

cctaaaatat tgatgctggt gttggtgtga cataatgcta tggccagaac tgaaacttag     4980

agttataatt catgtattag ggttctccag agggacagaa ttagtaggat atatgtatat     5040

atgaaaggga ggttattagg gagaactggc tcccacagtt agaaggcgaa gtcgcacaat     5100

aggccgtctg caagctgggt tagagagaag ccagtagtgg ctcagcctga gttcaaaaac     5160

ctcaaaactg gggaagctga cagtgcagcc agccttcagt ctgtggccaa aggcccaaga     5220

gcccctggca accaacccac tggtgcaagt cctagattcc aaaggctgaa gaacctggag     5280

tctgatgtcc aagagcagga agagtggaag aaagccagaa gactcagcaa acaaggtaga     5340

cagtgtctac caccatagtg gccataccaa agaggctacc gattccttcc tgctacctgg     5400

atccctgaag ttgccctggt ctctgcacct tctaaaccta gttcttaaga gctttccatt     5460

acatgagctg tctcaaagcc ctccaataaa ttctcagtgt aagcttctgt tgcttgtgga     5520

cagaaaattc tgacagacct accctataag tgttactgtc aggataacat gagaacgcac     5580

aacagtaagt ggtcactaag tgttagctac ggttattttg cccaaggtag catggctagt     5640

tgatgccggt tgatggggct taaacccagc tccctcatct tccaggcctc tgtactccct     5700

attccactaa actacctctc aggtttattt ttttaaattc ttactctgca agtacatagg     5760

accacattta cctgggaaaa caagaataaa ggctgctctg cattttttag aaactttttt     5820

gaaagggaga tgggaatgcc tgcaccccca agtccagacc aacacaatgg ttaattgaga     5880

tgaataataa aggaaagact gttctgggct tcccagaata gcttggtcct taaattgtgg     5940

cacaaacaac ctcctgtcag agccagcctc ctgccaggaa gaggggtagg agactagagg     6000

ccgtgtgtgc agccttgccc tgaaggctag ggtgacaatt tggaggctgt ccaaacaccc     6060

tggcctctag agctggcctg tctatttgaa atgccggctc tgatgctaat cggcgaccct     6120

caggcaagtt acttaacctt acatgcctca gttttctcat ctggaaaatg agaaccctag     6180

gtttagggtt gttagaaaag ttaaatgagt taagacaagt gcctgggaca cagtagcctc     6240

ttgtgtgtgt ttatcattat gtcctcagca ggtcgtagaa gcagcttctc aggtgtgagg     6300

ctggcgcgat tatctggagt gggttgggtt ttctaggatg gaccccctgc tgcattttcc     6360

tcattcatcc accagggctt aatggggaat caaggaatcc atgtgtaact gtataataac     6420

tgtagccaca ctccaatgac cacctactag ttgtccctgg cactgcttat acatatgtcc     6480

atcaaatcaa tcctatgaag tagatactgt cttcatttta tagatcagag acaattgggg     6540

ttcagagagc tgatgtgatt ttcccagggt cacagagagt cccagattca ggcacaactc     6600

ttgtattcca agacacaacc actacatgtc caaaggctgc ccagagccac cgggcacggc     6660

aaattgtgac atatccctaa agaggctgag cacctggtca ggatctgatg gctgacagtg     6720

tgtccagatg cagagctgga gtgggggagg ggaagggggg ctccttggga cagagaaggc     6780

tttctgtgct ttctctgaag ggagcagtct gaggaccaag ggaacccggc aaacagcacc     6840

tcaggtactc caggccctcc tggctggaga gggctgtggc aatggaaaat tagtgccaac     6900

tgcaatgagt cagcctcggt taaatagaga gtgaagaatg ctggacagga acctccaccc     6960

tcatgtcaca tttcttcagt gtgacccttc tggcccctct cctcctgaca gcggaacaat     7020

gactgccccg ataggtgagg ctggaggaag aatcagtcct gtccttggca agctcttcac     7080

tatgacagta aaggctctct gcctgctgcc aaggcctgtg actttctaac ctggcctcac     7140

gctgggtaag cttaaggtag aggtgcagga ttagcaagcc cacctggcta ccaggccgac     7200

agctacatct ttcaactgac cctgatcaac gaagagggac ttgtgtctct cagttggttc     7260

caaatgaaac cagggagcag gggcgttagg aagctccaac aggatggtac ttaatggggc     7320

atttgagtgg agaggtaggt gacatagtgc tttggagccc agggagggaa aggttctgct     7380

gaagttgaat tcaagactgt tctttcatca caaacttgag tttcctggac atttgtttgc     7440

agaaacaacc gtagggtttt gccttaacct cgtgggttta ttattacctc atagggactt     7500

tgcctcctga cagcagttta tgggtgttca ttgtggcact tgagttttct tgcatacttg     7560

ttagagaaac caagtttgtc atcaacttct tatttaaccc cctggctata acttcatgga     7620

ttatgttata attaagccat ccagagtaaa atctgtttag attatcttgg agtaaggggg     7680

aaaaaatctg taattttttc tcctcaacta gatatataca taaaaaatga ttgtattgct     7740

tcatttaaaa aatataacgc aaaatctctt ttccttctaa aaaaaaaaaa aaaaaa         7796


<210>  342
<211>  128
<212>  PRT
<213>  Homo sapiens

<400>  342

Met Gly Ile Gln Gly Gly Ser Val Leu Phe Gly Leu Leu Leu Val Leu 
1               5                   10                  15      


Ala Val Phe Cys His Ser Gly His Ser Leu Gln Cys Tyr Asn Cys Pro 
            20                  25                  30          


Asn Pro Thr Ala Asp Cys Lys Thr Ala Val Asn Cys Ser Ser Asp Phe 
        35                  40                  45              


Asp Ala Cys Leu Ile Thr Lys Ala Gly Leu Gln Val Tyr Asn Lys Cys 
    50                  55                  60                  


Trp Lys Phe Glu His Cys Asn Phe Asn Asp Val Thr Thr Arg Leu Arg 
65                  70                  75                  80  


Glu Asn Glu Leu Thr Tyr Tyr Cys Cys Lys Lys Asp Leu Cys Asn Phe 
                85                  90                  95      


Asn Glu Gln Leu Glu Asn Gly Gly Thr Ser Leu Ser Glu Lys Thr Val 
            100                 105                 110         


Leu Leu Leu Val Thr Pro Phe Leu Ala Ala Ala Trp Ser Leu His Pro 
        115                 120                 125             


